{"study_id": 37315, "supplement_id": 1109, "safety_score": "70", "efficacy_score": 80, "quality_score": 85, "study_goal": "The researchers aimed to determine whether chronic ephedrine treatment could induce adaptive thermogenesis and increase brown adipose tissue (BAT) activity in healthy young men.", "results_summary": "Chronic ephedrine treatment significantly reduced total body fat and visceral fat but did not increase BAT activity; instead, it suppressed BAT glucose disposal. The active group showed reduced BAT activity and systolic blood pressure response to acute ephedrine compared to placebo.", "population_specificity": "Healthy young men (non-smokers, physically inactive, non-medicated, no prior cardiovascular disease or diabetes) from Melbourne, Australia.", "effective_dosage": "1.5 mg/kg/day", "study_duration": "28 days", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:45:49.246197+00:00"}
{"study_id": 37314, "supplement_id": 1109, "safety_score": "80", "efficacy_score": 90, "quality_score": 85, "study_goal": "The researchers aimed to compare the efficacy and safety of prophylactic ephedrine (30 mg i.m.) versus polygeline 3.5% (500 ml i.v.) for preventing hypotension after subarachnoid block in elderly patients.", "results_summary": "Ephedrine 30 mg i.m. was more effective than polygeline 3.5% i.v. in reducing the incidence of hypotension and the need for rescue therapy, with better maintenance of heart rates and few hemodynamic adverse effects in both groups.", "population_specificity": "Elderly patients (age > 50 years) undergoing orthopedic surgeries.", "effective_dosage": "30 mg intramuscularly, administered 10 minutes before subarachnoid block.", "study_duration": "Single dose administered prior to the procedure.", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:45:49.640802+00:00"}
{"study_id": 37317, "supplement_id": 1109, "safety_score": "50", "efficacy_score": 30, "quality_score": 40, "study_goal": "To assess the effects and adverse effects of ephedrine in people with autoimmune myasthenia gravis (MG), transient neonatal MG, and congenital myasthenic syndromes (CMSs).", "results_summary": "No RCTs or quasi-RCTs were found to establish ephedrine's effects on MG, NMG, or CMSs. Non-randomized studies reported mixed observations on endurance, muscle strength, and quality of life, with adverse effects including tachycardia, sleep disturbances, nervousness, and withdrawal symptoms.", "population_specificity": "Adults and children with autoimmune MG, transient neonatal MG, or congenital myasthenic syndromes (CMSs).", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:45:50.275558+00:00"}
{"study_id": 37320, "supplement_id": 1109, "safety_score": "70", "efficacy_score": 85, "quality_score": 90, "study_goal": "The researchers aimed to evaluate the dose effects of ephedrine pretreatment on the onset time and intubating conditions after cisatracurium administration.", "results_summary": "Ephedrine pretreatment (70 or 110 \u00b5g/kg) significantly improved intubating conditions and reduced onset time of neuromuscular block compared to placebo, though higher doses (110 \u00b5g/kg) caused marked hypertension in some patients.", "population_specificity": "140 adult patients undergoing anesthesia.", "effective_dosage": "30 \u00b5g/kg, 70 \u00b5g/kg, or 110 \u00b5g/kg ephedrine, administered once as pretreatment.", "study_duration": "Single-dose intervention, effects measured 1.5 min after administration.", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:45:50.277036+00:00"}
{"study_id": 37318, "supplement_id": 1109, "safety_score": "65", "efficacy_score": 75, "quality_score": 85, "study_goal": "The researchers aimed to compare the efficacy and safety of ephedrine, phenylephrine, and metaraminol in preventing and treating hypotension after spinal anesthesia for cesarean section.", "results_summary": "Ephedrine was effective in preventing hypotension but had a higher incidence of nausea, vomiting, and fetal acidosis compared to the other vasopressors. The adverse effects were transient, and no differences were found in other outcomes like Apgar scores or bradycardia.", "population_specificity": "Pregnant women not in labor undergoing cesarean section (n=90).", "effective_dosage": "4mg bolus followed by 4mg/min continuous infusion, with adjustments based on blood pressure.", "study_duration": "Duration of the cesarean section procedure (exact time not specified).", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:45:50.329588+00:00"}
{"study_id": 37321, "supplement_id": 1109, "safety_score": "Not Assessed", "efficacy_score": 65, "quality_score": 80, "study_goal": "The researchers aimed to determine whether the thermogenic effect of Ephedrine/caffeine (EC) in morbidly obese women was linked to up-regulation of uncoupling protein 3 (UCP3) gene expression in skeletal muscle.", "results_summary": "EC treatment increased resting metabolic rate (RMR) but did not affect UCP3 gene expression. Weight loss occurred in both EC and placebo groups, with no significant differences between them. No changes were observed in other metabolic parameters.", "population_specificity": "Morbidly obese women (BMI 48.0\u00b14.0 kg/m\u00b2, aged 25-52 years).", "effective_dosage": "200 mg ephedrine / 20 mg caffeine, administered three times daily.", "study_duration": "4 weeks", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:45:56.972873+00:00"}
{"study_id": 37322, "supplement_id": 1109, "safety_score": "80", "efficacy_score": 90, "quality_score": 85, "study_goal": "The researchers aimed to compare the effects of ephedrine and phenylephrine on frontal lobe oxygenation (ScO2), maternal hemodynamics, and fetal heart rate during caesarean section with spinal anesthesia.", "results_summary": "Ephedrine maintained ScO2 and maternal heart rate better than phenylephrine, with no significant difference in mean arterial pressure or cardiac output between groups. Both drugs elicited a similar increase in fetal heart rate.", "population_specificity": "24 women undergoing caesarean section with spinal anesthesia.", "effective_dosage": "0.8-3.3 mg/min (ephedrine infusion).", "study_duration": "Duration of surgery (not explicitly stated).", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:45:57.495109+00:00"}
{"study_id": 37324, "supplement_id": 1109, "safety_score": "Not Assessed", "efficacy_score": 45, "quality_score": 75, "study_goal": "The researchers aimed to investigate whether ephedrine could provide therapeutic benefits for slow channel congenital myasthenic syndrome using a transgenic mouse model.", "results_summary": "Treated mice showed modest improvements in screen hang time and some electromyography measures, but these benefits were not statistically significant. The study concluded that ephedrine had only a modest potential benefit for this condition.", "population_specificity": "Transgenic mice modeling slow channel congenital myasthenic syndrome.", "effective_dosage": "Oral ephedrine (serum concentration 89 \u00b1 3 ng/ml).", "study_duration": "Six weeks.", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:45:58.061140+00:00"}
{"study_id": 37323, "supplement_id": 1109, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 75, "study_goal": "The researchers aimed to investigate the anti-inflammatory effects of pseudoephedrine/ephedrine in a rat model of LPS-induced acute liver failure, focusing on effects beyond their known sympathomimetic properties.", "results_summary": "Pseudoephedrine and ephedrine significantly reduced inflammatory cell infiltration, hepatic necrosis, and hepatocellular apoptosis, while lowering TNF-\u03b1 production and other markers of liver damage. Both compounds inhibited NF-\u03baB activation and TNF-\u03b1 transcription in Kupffer cells, suggesting a comprehensive anti-inflammatory mechanism.", "population_specificity": "Male rats sensitized with D-galactosamine and LPS to induce acute liver failure.", "effective_dosage": "Intraperitoneal administration at 0 h and 4 h after induction (exact dosage not specified).", "study_duration": "Acute intervention over 4 hours.", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:45:59.318790+00:00"}
{"study_id": 37325, "supplement_id": 1109, "safety_score": "Not Assessed", "efficacy_score": 75, "quality_score": 85, "study_goal": "The researchers aimed to evaluate the effects of caffeine/ephedrine combination (CE) and leptin A-200, alone or combined, on weight loss and visceral fat reduction in obese subjects.", "results_summary": "CE and CE combined with leptin (LCE) led to significant weight loss and fat mass reduction, with LCE also reducing visceral fat. Leptin alone was ineffective, and no additive or synergistic effects were observed when combined with CE.", "population_specificity": "90 obese subjects", "effective_dosage": "200 mg caffeine/20 mg ephedrine three times daily (t.i.d.)", "study_duration": "24 weeks", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:45:59.525155+00:00"}
{"study_id": 37327, "supplement_id": 1109, "safety_score": "80", "efficacy_score": 75, "quality_score": 85, "study_goal": "The researchers aimed to compare the effects of ephedrine and phenylephrine on cerebral hemodynamics during carotid endarterectomy, particularly focusing on cerebral tissue oxygenation and middle cerebral artery blood velocity.", "results_summary": "The study found that ephedrine preserved frontal lobe cerebral tissue oxygenation better than phenylephrine in patients with intact cerebral auto-regulation, though the specific outcomes for carotid endarterectomy patients were not yet reported.", "population_specificity": "Patients undergoing carotid endarterectomy.", "effective_dosage": "5 to 10 mg ephedrine (bolus administration).", "study_duration": "Single intraoperative administration (duration not specified).", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:46:01.108240+00:00"}
{"study_id": 37326, "supplement_id": 1109, "safety_score": "Not Assessed", "efficacy_score": 75, "quality_score": 80, "study_goal": "The researchers aimed to determine the molecular mechanism by which Ephedrine induces Trx-1 expression and its potential signaling pathway in rat pheochromocytoma PC12 cells.", "results_summary": "Ephedrine induced Trx-1 expression via the \u03b2-adrenergic receptor/cyclic AMP/PKA/DARPP-32 signaling pathway and increased PKA-mediated CREB phosphorylation, enhancing cell viability in PC12 cells. DARPP-32 siRNA reduced Trx-1 expression, but Trx-1 siRNA did not affect DARPP-32.", "population_specificity": "Rat pheochromocytoma PC12 cells (in vitro study).", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "Propranolol (\u03b2-adrenergic receptor inhibitor), phenoxybenzamine (\u03b1-adrenergic receptor inhibitor), SQ22536 (adenylyl cyclase inhibitor), and H-89 (protein kinase A inhibitor) were used to study interactions.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:46:02.082909+00:00"}
{"study_id": 37328, "supplement_id": 1109, "safety_score": "90", "efficacy_score": 85, "quality_score": 70, "study_goal": "To determine if oral ephedrine hydrochloride is effective for treating resistant non-neurogenic daytime urinary incontinence in children.", "results_summary": "94% of children reported symptom improvement, and 33% achieved complete continence. Post-treatment urodynamics showed compliant bladders, and no significant side effects were reported.", "population_specificity": "18 children (16 female, 2 male) aged 5-15 years with resistant non-neurogenic daytime urinary incontinence.", "effective_dosage": "Started at 7.5 mg or 15 mg twice daily, titrated up to 30 mg four times daily.", "study_duration": "Median follow-up of 7 years (range 6-8 years).", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:46:05.903650+00:00"}
{"study_id": 37329, "supplement_id": 1109, "safety_score": "80", "efficacy_score": 75, "quality_score": 85, "study_goal": "The researchers aimed to evaluate the efficacy of three combination methods, including ephedrine, to prevent maternal hypotension after spinal anesthesia during cesarean delivery.", "results_summary": "The study found that combining crystalloid preload with ephedrine was the most effective method to reduce hypotension, with no significant differences in adverse effects or neonatal outcomes among the groups. Hypothesis incidence was similar across all groups (40-46%).", "population_specificity": "150 candidates of elective cesarean delivery under spinal anesthesia.", "effective_dosage": "15 mg IV bolus of ephedrine.", "study_duration": "60 minutes after spinal injection.", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:46:05.970041+00:00"}
{"study_id": 37330, "supplement_id": 1109, "safety_score": "Not Assessed", "efficacy_score": 70, "quality_score": 85, "study_goal": "The researchers aimed to determine whether oral ephedrine could activate brown adipose tissue (BAT) in lean and obese humans.", "results_summary": "Ephedrine increased BAT activity in lean participants but had no effect in obese participants. The change in BAT activity was negatively correlated with body fatness indices.", "population_specificity": "Nine lean (BMI 22 \u00b1 1 kg/m\u00b2) and nine obese (BMI 36 \u00b1 1 kg/m\u00b2) young men.", "effective_dosage": "2.5 mg/kg of oral ephedrine, single dose.", "study_duration": "Acute (single administration).", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:46:06.895318+00:00"}
{"study_id": 37332, "supplement_id": 1109, "safety_score": "70", "efficacy_score": 85, "quality_score": 75, "study_goal": "The researchers aimed to investigate Ephedrine's effects on psychomotor recovery and potential adverse reactions on cardiorespiratory functions in rhesus monkeys under anesthesia.", "results_summary": "Ephedrine significantly shortened recovery time from anesthesia, increased oxygen saturation and systolic blood pressure, and caused a notable decrease in pulse rate shortly after administration.", "population_specificity": "Rhesus monkeys", "effective_dosage": "1 mg/kg administered intramuscularly", "study_duration": "Monitoring occurred for 20 minutes post-anesthesia, with follow-up every 5 minutes after Ephedrine administration.", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:46:07.588604+00:00"}
{"study_id": 37331, "supplement_id": 1109, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 90, "study_goal": "The researchers aimed to determine the impact of acepromazine on the cardiovascular responses to ephedrine and other treatments for hypotension in dogs under deep isoflurane anesthesia.", "results_summary": "Ephedrine significantly increased arterial blood pressure, cardiac output, hemoglobin, oxygen content, and delivery, effectively countering cardiovascular depression from deep anesthesia. However, initial vasoconstriction led to extreme blood pressure changes, making the studied dose potentially unsuitable for recommendation.", "population_specificity": "Six healthy adult mixed-breed dogs under deep isoflurane anesthesia.", "effective_dosage": "0.1 mg kg(-1) bolus followed by 10 \u03bcg kg(-1) minute(-1) infusion.", "study_duration": "Throughout the study (40 minutes).", "interactions": "Acepromazine pretreatment minimized blood pressure improvements with ephedrine.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:46:09.169257+00:00"}
{"study_id": 37333, "supplement_id": 1109, "safety_score": "Not Assessed", "efficacy_score": 65, "quality_score": 80, "study_goal": "The researchers aimed to evaluate the impact of prescription-only regulations for ephedrine and pseudoephedrine on methamphetamine clandestine laboratory seizures in Oregon and Mississippi.", "results_summary": "Oregon's regulation showed no significant impact on lab seizures, likely due to a floor effect, while Mississippi experienced a 50.2% drop in seizures post-regulation. Nearby states without regulation showed no comparable decline.", "population_specificity": "States implementing prescription regulations (Oregon, Mississippi) and nearby quasi-control states.", "effective_dosage": "Not mentioned", "study_duration": "Data analyzed from 2000 to early 2011.", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:46:09.658304+00:00"}
{"study_id": 37334, "supplement_id": 1109, "safety_score": "Not Assessed", "efficacy_score": 75, "quality_score": 80, "study_goal": "The researchers aimed to compare the mechanistic differences in weight loss between ephedrine, exercise, and dietary restriction by examining gene expression and histopathologic changes in brown adipose tissue and liver.", "results_summary": "Ephedrine reduced body fat and BAT/liver lipid accumulation, increased oxygen consumption, and up-regulated mitochondrial biogenesis genes (TFAM, NRF1, GABPA) and UCP-1, but did not significantly up-regulate PGC-1\u03b1 or fatty acid transport/metabolism genes compared to other interventions.", "population_specificity": "Diet-induced obese (DIO) mice", "effective_dosage": "18 mg/kg/day orally", "study_duration": "7 days", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:46:10.888993+00:00"}
{"study_id": 37319, "supplement_id": 1109, "safety_score": "Not Assessed", "efficacy_score": 75, "quality_score": 80, "study_goal": "The researchers aimed to investigate the effects of ephedrine on mitochondrial health, body weight, and fat mass in diet-induced obese mice.", "results_summary": "Ephedrine treatment significantly reduced body weight and fat mass in obese mice, improved mitochondrial ultrastructure in brown adipose tissue, and increased cardiolipin species, indicating enhanced mitochondrial biogenesis.", "population_specificity": "Diet-induced obese (DIO) mice", "effective_dosage": "200 mg kg(-1) day(-1) orally", "study_duration": "7 days", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:46:11.042651+00:00"}
{"study_id": 37335, "supplement_id": 1109, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 75, "study_goal": "The researchers aimed to determine whether ephedrine hydrochloride (EH) could modulate immune responses by balancing proinflammatory and anti-inflammatory cytokine production in TLR4 signaling, potentially protecting against endotoxic shock.", "results_summary": "EH increased IL-10 production and inhibited TNF\u03b1, protecting mice from lethal LPS-induced endotoxic shock by promoting immune homeostasis. The effects were mediated through p38 MAPK activation.", "population_specificity": "Mice (animal study)", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:46:13.510751+00:00"}
{"study_id": 37336, "supplement_id": 1109, "safety_score": "Not Assessed", "efficacy_score": null, "quality_score": 85, "study_goal": "The researchers aimed to develop a method for identifying and quantifying enantiomers of ephedrine and related compounds in plasma using chiral capillary GC-MS.", "results_summary": "The study successfully developed a sensitive and precise GC-MS method for detecting stereoisomers of ephedrine and related compounds in plasma, with linear detection ranges and low detection limits. The method was effective for analyzing plasma from humans and guinea pigs.", "population_specificity": "Human users of over-the-counter cold medicines and guinea pigs treated with racemic ephedrine.", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:46:14.748330+00:00"}
{"study_id": 187846, "supplement_id": 1109, "safety_score": "30", "efficacy_score": 50, "quality_score": 40, "study_goal": "The researchers aimed to critically review the available evidence on the acute and/or long-term harms of DMAA, an ephedrine-like substance.", "results_summary": "The study found mixed evidence on DMAA's effects, with acute dosing linked to blood pressure escalations and some reductions in body weight and fat, but the evidence base was shallow and inconclusive regarding safe consumption doses.", "population_specificity": "Patients presenting to emergency departments (case studies) and participants in experimental studies (broad physiological outcomes).", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:46:14.880943+00:00"}
{"study_id": 187847, "supplement_id": 1109, "safety_score": "Not Assessed", "efficacy_score": null, "quality_score": 85, "study_goal": "The study aimed to evaluate the impact of additional capnography on reducing oxygen desaturation and hypoxic events during propofol anesthesia in surgical abortion, not specifically focused on Ephedrine.", "results_summary": "The study did not report specific findings on Ephedrine's effects, only noting no significant differences in dosage between groups.", "population_specificity": "ASA I-III female patients aged 18-52 undergoing planned painless surgical abortion.", "effective_dosage": "Not specified (only noted no significant differences in dosage between groups).", "study_duration": "Duration of intervention not specified.", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:46:15.921539+00:00"}
{"study_id": 187849, "supplement_id": 1109, "safety_score": "Not Assessed", "efficacy_score": null, "quality_score": null, "study_goal": "The researchers aimed to highlight the risks of dietary supplements, including Ephedrine, in the context of doping and performance enhancement among athletes.", "results_summary": "The abstract does not provide specific findings on Ephedrine's effects but emphasizes the proliferation of performance-enhancing supplements, including those containing prohibited substances like Ephedrine, and the need for awareness to prevent accidental doping.", "population_specificity": "Athletes and individuals using dietary supplements for performance enhancement.", "effective_dosage": "Not mentioned", "study_duration": "Not mentioned", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:46:17.618373+00:00"}
{"study_id": 187848, "supplement_id": 1109, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 90, "study_goal": "The researchers aimed to evaluate the influence of epidural volume restriction on the incidence of hypotension and ephedrine supplementation during spinal anesthesia for Caesarean sections.", "results_summary": "The study found that the CSE-EVR group had a significantly lower incidence of hypotension and required less ephedrine supplementation compared to the SA group, while maintaining adequate anesthesia and better maternal hemodynamic stability.", "population_specificity": "60 full-term parturient women (ASA I or II) with uncomplicated pregnancies.", "effective_dosage": "Not specified (ephedrine use was noted but dosage not detailed).", "study_duration": "Duration of spinal anesthesia during and immediately after Caesarean section.", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:46:18.143755+00:00"}
{"study_id": 187851, "supplement_id": 1109, "safety_score": "30", "efficacy_score": null, "quality_score": 75, "study_goal": "The researchers aimed to examine ephedrine policy over time to identify regulatory flaws that allowed its misuse to persist.", "results_summary": "The study found that ephedrine passed through regulatory loopholes for decades, remaining easily available despite warnings of misuse. Under-regulation was a significant issue, and tighter control might have prevented adverse outcomes.", "population_specificity": "Not specified (historical and scientific literature review)", "effective_dosage": "Not mentioned", "study_duration": "Not mentioned", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:46:18.690283+00:00"}
{"study_id": 187850, "supplement_id": 1109, "safety_score": "Not Assessed", "efficacy_score": 75, "quality_score": 60, "study_goal": "The researchers aimed to highlight the cardiovascular risks of dexmedetomidine and the potential use of ephedrine to counteract its adverse effects.", "results_summary": "The study found that ephedrine, along with atropine and volume supplementation, could counteract dexmedetomidine-induced bradycardia and hypotension, though it primarily focused on the risks of dexmedetomidine rather than ephedrine's standalone effects.", "population_specificity": "Patients older than 50 years and those with cardiac abnormalities undergoing neurosurgical procedures.", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:46:18.853208+00:00"}
{"study_id": 12660, "supplement_id": 1110, "safety_score": "Not Assessed", "efficacy_score": 75, "quality_score": 85, "study_goal": "The researchers aimed to investigate the therapeutic potential of EGCG in modulating the miR-192/215-EGR1 axis in gastric cancer.", "results_summary": "EGCG transiently up-regulated miR-192/215 and down-regulated EGR1, suggesting its potential as a therapeutic agent for gastric cancer. The study also linked higher EGR1 levels to poorer survival outcomes.", "population_specificity": "Gastric cancer patients (institutional cohort n=56) and cell line models.", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:46:21.516806+00:00"}
{"study_id": 12661, "supplement_id": 1110, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 78, "study_goal": "The researchers aimed to determine whether EGCG-loaded menstrual blood-derived exosomes could enhance endometrial receptivity and improve embryo implantation.", "results_summary": "EGCG-loaded exosomes improved endometrial cell adhesion and upregulated receptivity-related genes (Leukemia inhibitory factor, homeobox A10, integrin beta 3) more effectively than free EGCG. The encapsulation efficiency of EGCG in exosomes was 65.18%.", "population_specificity": "In vitro study using endometrial cells; no human subjects specified.", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:46:23.226795+00:00"}
{"study_id": 12663, "supplement_id": 1110, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 78, "study_goal": "The researchers aimed to investigate the antibacterial effects of epigallocatechin gallate (EGCG) on Escherichia coli, focusing on disinfection damage mechanisms and bacterial response to oxidative stress.", "results_summary": "EGCG caused dose- and duration-dependent damage to E. coli, inducing oxidative stress and altering the bacterial antioxidant system. Transcriptomic analysis revealed E. coli adjusted gene expression related to peroxidase and glutathione metabolism to counteract EGCG-induced oxidative damage.", "population_specificity": "Escherichia coli (bacterial culture)", "effective_dosage": "Different concentrations (specific amounts not provided)", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:46:25.042883+00:00"}
{"study_id": 12666, "supplement_id": 1110, "safety_score": "85", "efficacy_score": 90, "quality_score": 80, "study_goal": "The researchers aimed to develop a hydrogel contact lens incorporating EGCG to enhance antibacterial and antioxidant properties for treating bacterial keratitis.", "results_summary": "The hydrogel CL with EGCG demonstrated strong antibacterial activity against S. aureus and E. coli, good biocompatibility, antioxidant properties, and ROS scavenging ability, and was more effective than levofloxacin in reducing BK treatment duration without harming eye tissue.", "population_specificity": "Animal models (specific species not mentioned).", "effective_dosage": "Not specified.", "study_duration": "Not specified.", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:46:26.669809+00:00"}
{"study_id": 12667, "supplement_id": 1110, "safety_score": "85", "efficacy_score": 90, "quality_score": 80, "study_goal": "The researchers aimed to determine whether intranasal delivery of EGCG-loaded platelet extracellular vesicles (pEVs) could safely and effectively overcome ocular barriers and mitigate glaucoma progression.", "results_summary": "The study found that intranasal administration of EGCG-pEVs was safe, improved drug bioavailability, and demonstrated superior therapeutic efficacy, including anti-inflammatory, immunomodulatory, and intraocular pressure-reducing effects compared to other administration routes.", "population_specificity": "Animal model (dexamethasone-induced glaucoma)", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:46:26.724990+00:00"}
{"study_id": 12665, "supplement_id": 1110, "safety_score": "85", "efficacy_score": 75, "quality_score": 80, "study_goal": "The researchers aimed to determine whether green tea extract standardized to EGCG reduces folate levels and to evaluate its safety in reproductive-age women, including those with uterine fibroids.", "results_summary": "The study found that a 30-day course of EGCG (720 mg daily) alone or combined with clomiphene or letrozole did not cause folate deficiency, even in women with MTHFR/DHFR polymorphisms. Folate levels remained normal, and the treatment was well-tolerated.", "population_specificity": "Reproductive-age women (18\u201340 years), with or without uterine fibroids.", "effective_dosage": "720 mg of green tea extract (standardized to EGCG) daily.", "study_duration": "30 days.", "interactions": "Combined with clomiphene citrate or letrozole for 5 days.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:46:28.794906+00:00"}
{"study_id": 12668, "supplement_id": 1110, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 75, "study_goal": "The researchers aimed to investigate the neuroprotective role of EGCG in Parkinson's disease (PD) and its underlying mechanisms, particularly its effects on oxidative stress, inflammation, and motor function.", "results_summary": "EGCG was found to upregulate PKD1, inhibit Parthanatos, improve motor function, reduce oxidative stress, and suppress inflammation in the substantia nigra of PD rats, suggesting potential therapeutic benefits for PD.", "population_specificity": "Rotenone-induced PD rat model", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:46:29.851265+00:00"}
{"study_id": 12669, "supplement_id": 1110, "safety_score": "85", "efficacy_score": 90, "quality_score": 65, "study_goal": "The researchers aimed to determine whether an integrative treatment including Epigallocatechin Gallate (EGCG), humic/fulvic acid, and vitamin C could reduce mortality in COVID-19-positive nursing home patients.", "results_summary": "Among 22 patients receiving the integrative treatment, there were no mortalities, compared to 21 deaths in 38 untreated patients, suggesting a significant reduction in mortality with the treatment.", "population_specificity": "Nursing home patients with COVID-19 infections.", "effective_dosage": "Not specified", "study_duration": "October to December 2020 (exact duration per patient not specified)", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:46:31.886241+00:00"}
{"study_id": 12662, "supplement_id": 1110, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 75, "study_goal": "The researchers aimed to evaluate the anticancer activity of a nano-emulsion containing Epigallocatechin Gallate (EGCG) on head and neck squamous cell carcinoma (TSCC-1 cells).", "results_summary": "The nano-emulsion containing EGCG demonstrated significant anticancer activity, including cytotoxicity at 80 \u00b5g/mL, inhibition of cell migration, induction of apoptosis (88.3%), reduced colony formation, and decreased expression of BCL2 and VEGF genes while increasing BAX gene expression. The 3D culture also showed reduced spheroid growth in treated groups.", "population_specificity": "TSCC-1 cancer cell line (head and neck squamous cell carcinoma).", "effective_dosage": "80 \u00b5g/mL (concentration used in cytotoxicity assays).", "study_duration": "Not specified in the abstract.", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:46:34.334498+00:00"}
{"study_id": 12670, "supplement_id": 1110, "safety_score": "Not Assessed", "efficacy_score": 90, "quality_score": 85, "study_goal": "The researchers aimed to evaluate the effectiveness of gelatin-epigallocatechin gallate nanoparticles (GEH NPs) in treating keratoconjunctivitis sicca (KCS)-associated keratopathy compared to artificial tears in a rat model.", "results_summary": "GEH NPs showed superior outcomes, including reduced corneal irregularity, improved tear film stability, lower fluorescein scores, and less inflammatory cell infiltration compared to artificial tears, even with a lower dosing frequency.", "population_specificity": "Female Sprague-Dawley rats aged 6 to 8 weeks with induced KCS.", "effective_dosage": "GEH NPs administered twice daily (exact dosage not specified).", "study_duration": "2 weeks postoperatively.", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:46:34.348828+00:00"}
{"study_id": 12672, "supplement_id": 1110, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 75, "study_goal": "The researchers aimed to determine whether EGCG could reverse senescence-associated effects in vascular endothelial cells and mitigate pro-inflammatory responses in monocytes.", "results_summary": "EGCG reduced senescence markers in endothelial cells and decreased pro-inflammatory responses in monocytes co-cultured with senescent cells. EVs from EGCG-treated senescent cells also mitigated monocyte activation, suggesting EGCG's potential as a senotherapeutic agent.", "population_specificity": "Human umbilical vein endothelial cells (HUVECs) and monocytes in vitro.", "effective_dosage": "100 \u00b5M, 24 hours.", "study_duration": "24 hours.", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:46:35.414892+00:00"}
{"study_id": 12664, "supplement_id": 1110, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 75, "study_goal": "The researchers aimed to determine whether Epigallocatechin Gallate (EGCG) enhances the sensitivity of hepatocellular carcinoma (HCC) cells to cuproptosis and explore the underlying mechanisms.", "results_summary": "EGCG combined with copper ionophores significantly increased HCC cell mortality and sensitivity to cuproptosis by reducing ATP7B expression and suppressing MTF1, leading to intracellular copper accumulation. These effects were also observed in vivo, with EGCG promoting copper accumulation in tumors and enhancing cuproptosis susceptibility.", "population_specificity": "Hepatocellular carcinoma (HCC) cells and a nude mouse xenograft model.", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:46:35.416320+00:00"}
{"study_id": 12671, "supplement_id": 1110, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 78, "study_goal": "The researchers aimed to investigate Epigallocatechin Gallate (EGCG) as a natural inhibitor of Aurora Kinase B (AURKB) and its potential to enhance anti-cancer therapies through in silico and molecular dynamics analyses.", "results_summary": "The study found that EGCG binds stably to AURKB, inducing conformational changes (DFG-in to DFG-out state) that inhibit ATP binding and kinase activity, potentially reducing glioma cell chemosensitivity. Secondary structure transitions (e.g., turn to coil) further stabilized the EGCG-AURKB complex.", "population_specificity": "In silico and molecular dynamics study (no human or animal subjects).", "effective_dosage": "Not specified.", "study_duration": "100 ns molecular dynamics simulation.", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:46:36.296451+00:00"}
{"study_id": 12673, "supplement_id": 1110, "safety_score": "Not Assessed", "efficacy_score": 75, "quality_score": 65, "study_goal": "The researchers aimed to explore how Epigallocatechin Gallate (EGCG) may alleviate depression by interacting with gut microbiota and other mechanisms.", "results_summary": "The study suggests that EGCG, a major component of green tea, effectively regulates intestinal flora and may help alleviate depression by influencing gut-brain axis pathways, including the HPA axis, neurotransmitters, immune responses, and metabolic pathways.", "population_specificity": "Not specified (general discussion on depression and gut microbiota).", "effective_dosage": "Not provided", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:46:36.360183+00:00"}
{"study_id": 12674, "supplement_id": 1110, "safety_score": "Not Assessed", "efficacy_score": 65, "quality_score": 75, "study_goal": "The researchers aimed to review the anticancer effects of EGCG on breast, cervical, endometrial, and ovarian cancers based on literature from the last two decades.", "results_summary": "EGCG demonstrated antioxidant, antiproliferative, and antiangiogenic properties with potential anticancer effects, though effective concentrations were higher than those achievable in plasma. Low bioavailability and absorption were noted as challenges, with proposed solutions including combining EGCG with other bioactive components or using nanotechnology.", "population_specificity": "Women with breast, cervical, endometrial, and ovarian cancers (based on in vitro and animal model studies).", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:46:38.737393+00:00"}
{"study_id": 12677, "supplement_id": 1110, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 70, "study_goal": "The researchers aimed to evaluate the effects of EGCG on diabetes prognosis and insulin resistance in STZ-induced diabetic rats.", "results_summary": "EGCG significantly lowered fasting blood glucose levels, improved insulin secretion, reduced insulin resistance, and enhanced beta cell function, with the most pronounced effects at 200 mg/kg. The findings suggest EGCG may aid in diabetes management by improving glycemic control and insulin sensitivity.", "population_specificity": "Male Wistar albino rats with STZ-induced diabetes.", "effective_dosage": "50 mg/kg, 100 mg/kg, and 200 mg/kg.", "study_duration": "Not specified in the abstract.", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:46:43.018427+00:00"}
{"study_id": 12676, "supplement_id": 1110, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 75, "study_goal": "The researchers aimed to evaluate the synergistic inhibitory activity of Epigallocatechin Gallate (EGCG) and Nelfinavir (NFV) in a nanoemulsion formulation for HIV-1 suppression.", "results_summary": "The study found that the NE-NFV-EGCG nanoemulsion exhibited enhanced HIV-1 inhibitory activity compared to pure NFV, demonstrating a promising therapeutic synergy. Molecular interaction studies confirmed the nanoemulsion's inhibitory potential against the HIV-1 protease enzyme.", "population_specificity": "In vitro cellular systems (specific cell types not detailed in the abstract).", "effective_dosage": "Sub-CC\u2085\u2080 concentrations (specific dosage not provided).", "study_duration": "Not specified in the abstract.", "interactions": "Synergistic interaction with Nelfinavir (NFV) noted.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:46:43.767208+00:00"}
{"study_id": 12679, "supplement_id": 1110, "safety_score": "80", "efficacy_score": 85, "quality_score": 75, "study_goal": "The researchers aimed to explore the protective effect of EGCG on cisplatin-induced intestinal injury in rats.", "results_summary": "EGCG pretreatment effectively alleviated cisplatin-induced intestinal damage, with the 40 mg/kg dose showing the most substantial protective effect. It mitigated morphological and ultrastructural damage, reduced bacterial translocation, preserved intestinal barrier integrity, and influenced gut flora and metabolic pathways.", "population_specificity": "Rats with cisplatin-induced intestinal injury.", "effective_dosage": "20, 40, and 80 mg/kg.", "study_duration": "Not specified in the abstract.", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:46:44.708852+00:00"}
{"study_id": 12680, "supplement_id": 1110, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 75, "study_goal": "The researchers aimed to determine whether polyphenol oxidase-mediated EGCG could improve the thermal stability of A. japonicus body wall proteins and mitigate protein degradation during heat treatment.", "results_summary": "Polyphenol oxidase-mediated EGCG induced protein aggregation, enhanced antioxidant and thermal stability, and inhibited digestive properties while maintaining protein microstructure post-heat treatment.", "population_specificity": "A. japonicus (sea cucumber) body wall proteins", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:46:45.117194+00:00"}
{"study_id": 12681, "supplement_id": 1110, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 75, "study_goal": "The researchers aimed to determine the impact of Epigallocatechin Gallate (EGCG) on the development of S. mutans biofilms, assessing its potential as a preventive agent against dental caries.", "results_summary": "EGCG treatment significantly reduced biofilm biomass, matrix volume, and thickness, delaying biofilm development and impairing initial growth and maturation compared to the negative control. The 46-hour biofilm in the EGCG group resembled the 24-hour biofilm of the control, indicating slowed progression.", "population_specificity": "S. mutans biofilms on hydroxyapatite discs (in vitro study).", "effective_dosage": "Not specified", "study_duration": "24 and 46 hours", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:46:45.777023+00:00"}
{"study_id": 12682, "supplement_id": 1110, "safety_score": "85", "efficacy_score": 90, "quality_score": 80, "study_goal": "The researchers aimed to develop and evaluate a carrier-free, dual-loaded nanodrug (Met-EGCG NPs) combining Epigallocatechin Gallate (EGCG) and metformin to enhance therapeutic efficacy while reducing side effects.", "results_summary": "The study found that Met-EGCG NPs exhibited strong antioxidant capacity, improved drug solubility and stability, reduced side effects, and demonstrated synergistic therapeutic effects, particularly in anti-cancer applications.", "population_specificity": "Not specified (in vitro or preclinical study implied).", "effective_dosage": "Not specified.", "study_duration": "Not specified.", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:46:46.536601+00:00"}
{"study_id": 12678, "supplement_id": 1110, "safety_score": "Not Assessed", "efficacy_score": 90, "quality_score": 85, "study_goal": "The researchers aimed to determine whether Epigallocatechin Gallate (EGCG) could restore the effectiveness of ampicillin against multidrug-resistant Escherichia coli strains.", "results_summary": "EGCG demonstrated antimicrobial activity against all tested MDR E. coli strains, with synergistic effects when combined with ampicillin, significantly reducing MIC values and achieving rapid bactericidal effects within 2 hours. The combination also disrupted membrane permeability and eradicated biofilms more effectively than either treatment alone.", "population_specificity": "Multidrug-resistant Escherichia coli strains (40 isolated strains).", "effective_dosage": "EGCG MIC ranged from 0.5 to 2 mg/mL; synergistic dosage reduced EGCG to 8 \u00b5g/mL and ampicillin to 50 \u00b5g/mL.", "study_duration": "Not specified in the abstract.", "interactions": "Synergistic interaction with ampicillin noted.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:46:46.987819+00:00"}
{"study_id": 12684, "supplement_id": 1110, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 75, "study_goal": "The researchers aimed to determine whether EGCG, combined with ice glazing, could inhibit melanosis and oxidation in frozen E. sinensis and maintain its quality during storage.", "results_summary": "EGCG inhibited PPO activity dose-dependently and altered its tertiary structure. Combined with ice glazing, it significantly reduced melanosis and oxidation, improving melanosis scores by 77.17% and reducing protein and lipid oxidation by 10.80% and 62.46%, respectively.", "population_specificity": "Frozen Eriocheir sinensis (aquatic product)", "effective_dosage": "0.1 g/L EGCG", "study_duration": "Six-week storage", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:46:52.533855+00:00"}
{"study_id": 12685, "supplement_id": 1110, "safety_score": "85", "efficacy_score": 90, "quality_score": 80, "study_goal": "The researchers aimed to summarize the beneficial effects, mechanisms, and application forms of EGCG in repairing photoaged skin caused by UV radiation.", "results_summary": "EGCG improved skin elasticity, enhanced moisturization, inhibited damage, and reduced pigmentation in photoaged skin. Modified EGCG delivery systems and combinations with other bioactive substances were found to enhance its effectiveness despite poor stability and low bioavailability.", "population_specificity": "Individuals with UV-induced skin photoaging.", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:46:53.043966+00:00"}
{"study_id": 12687, "supplement_id": 1110, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 75, "study_goal": "The researchers aimed to determine whether the triple-drug combination of temozolomide, metformin, and epigallocatechin gallate could attenuate the Warburg effect and reduce glucose uptake in glioblastoma.", "results_summary": "The triple-drug combination significantly reduced glucose uptake and reversed the Warburg effect in glioblastoma cells and a glioma-induced xenograft rat model, suggesting potential therapeutic efficacy.", "population_specificity": "Glioblastoma cells (in vitro) and a glioma-induced xenograft rat model (in vivo).", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:46:54.365434+00:00"}
{"study_id": 12686, "supplement_id": 1110, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 75, "study_goal": "The researchers aimed to investigate the effects and mechanisms of a COS-EGCG conjugate (CE) on reducing obesity and promoting white adipose tissue browning in high-fat diet-fed rats.", "results_summary": "CE reduced body weight, improved serum lipid profiles, activated AMPK in white adipose tissue, and enhanced browning via Sirt1, PGC1-\u03b1, and UCP1 pathways, suggesting potential as an anti-obesity therapy.", "population_specificity": "Male Wistar rats fed a high-fat diet for 16 weeks.", "effective_dosage": "150 mg/kg/day and 600 mg/kg/day of CE.", "study_duration": "4 weeks.", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:46:55.458203+00:00"}
{"study_id": 12688, "supplement_id": 1110, "safety_score": "85", "efficacy_score": 75, "quality_score": 70, "study_goal": "The researchers aimed to review the efficacy and mechanisms of Epigallocatechin-3-gallate (EGCG) against sexually transmitted viruses and its potential as a safe bioactive phytochemical for preventing and treating viral STIs.", "results_summary": "The study found that EGCG, the most abundant polyphenol in green tea, has protective roles in preventing diseases, including antiviral effects against sexually transmitted viruses. EGCG and its derivatives are considered safe for external and internal use in treating viral STIs and concurrent infections.", "population_specificity": "Not specified (general review of existing studies).", "effective_dosage": "Not specified.", "study_duration": "Not specified.", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:46:55.595286+00:00"}
{"study_id": 12689, "supplement_id": 1110, "safety_score": "Not Assessed", "efficacy_score": 75, "quality_score": 80, "study_goal": "The researchers aimed to explore the potential of PLGA-based nanocarriers to enhance the therapeutic efficacy and bioavailability of Epigallocatechin Gallate (EGCG) for cancer treatment.", "results_summary": "The study highlights that EGCG has strong anticancer properties but faces challenges like limited solubility and bioavailability. Encapsulating EGCG in PLGA nanoparticles improves its delivery to tumor sites and enhances its effectiveness.", "population_specificity": "Not specified (general focus on cancer treatment applications).", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:46:55.660339+00:00"}
{"study_id": 12683, "supplement_id": 1110, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 75, "study_goal": "The researchers aimed to determine whether fibrin scaffold-encapsulated EGCG microspheres could enhance recovery from traumatic spinal cord injury in rats by reducing injury spread and improving pathological and behavioral symptoms.", "results_summary": "The Fibrin+EGCG group showed significant improvements in neuronal levels, antioxidative biomarkers, neurofilament light polypeptide (NEFL) and interleukin 10 (IL-10) genes, and neurological function scores, along with reduced apoptotic and glial cells, malondialdehyde (MDA), and proinflammatory genes (TNF-\u03b1 and IL-1\u03b2) compared to the TSCI group.", "population_specificity": "Mature male Sprague-Dawley rats with induced traumatic spinal cord injury.", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:46:57.367288+00:00"}
{"study_id": 12675, "supplement_id": 1110, "safety_score": "70", "efficacy_score": 80, "quality_score": 85, "study_goal": "The researchers aimed to review clinical findings on the safety and effectiveness of EGCG in managing obesity and NAFLD, focusing on treatment duration and dose effects.", "results_summary": "EGCG was associated with positive effects on metabolic biomarkers, waist circumference, and body weight in individuals with obesity and NAFLD, but some reports suggested potential hepatotoxicity.", "population_specificity": "Individuals affected by obesity and non-alcoholic fatty liver disease (NAFLD).", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:46:59.089378+00:00"}
{"study_id": 12690, "supplement_id": 1110, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 75, "study_goal": "The researchers aimed to determine whether an oral combination of EGCG, folic acid, vitamin B12, and hyaluronic acid could reduce HPV positivity and improve cervical lesions in women with HPV infection.", "results_summary": "The treatment group showed a significant reduction in HPV positivity and improvement in cervical lesions at both 3-month and 6-month follow-ups compared to the control group.", "population_specificity": "163 women with a positive HPV DNA test or history of HPV infections and PAP test indicating LSIL/AGUS/ASCUS cytology.", "effective_dosage": "EGCG 200 mg, FA 400 \u00b5g, vitamin B12 1 mg, and HA 50 mg (1 capsule/day).", "study_duration": "3 months (with follow-up at 6 months).", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:47:02.505292+00:00"}
{"study_id": 12692, "supplement_id": 1110, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 90, "study_goal": "The researchers aimed to optimize the oral delivery of Epigallocatechin Gallate (EGCG) in combination with Nelfinavir (NFV) via a nanoemulsion to enhance antiretroviral effects for NeuroAIDS treatment.", "results_summary": "The optimized nanoemulsion significantly improved the absorption of EGCG, achieving higher plasma (313.20 \u00b1 5.53 \u03bcg/mL) and brain (27.7 \u00b1 1.22 \u03bcg/mL) concentrations compared to suspension, demonstrating enhanced efficacy for NeuroAIDS management.", "population_specificity": "The study focused on in vivo models (specific population not detailed in the abstract).", "effective_dosage": "Not specified in the abstract.", "study_duration": "Not specified in the abstract.", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:47:02.606395+00:00"}
{"study_id": 12696, "supplement_id": 1110, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 75, "study_goal": "The researchers aimed to evaluate the effect of EGCG on MAL-PDT efficacy, PpIX production, and clonogenic capability in the A-431 cell line.", "results_summary": "EGCG (<50 \u00b5M) improved MAL-PDT cytotoxicity by increasing PpIX and ROS levels, inhibited clonogenic capability, and modulated HGS enzyme gene expression (upregulated PGB, downregulated FECH).", "population_specificity": "A-431 cell line (human epidermoid carcinoma cells).", "effective_dosage": "<50 \u00b5M", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:47:03.846409+00:00"}
{"study_id": 12693, "supplement_id": 1110, "safety_score": "Not Assessed", "efficacy_score": 75, "quality_score": 85, "study_goal": "The researchers aimed to investigate the mechanistic action of EGCG in targeting fibrotic pathways, specifically its interaction with SFRP2 and TGF-\u03b2, in patients with mild interstitial lung disease (ILD).", "results_summary": "EGCG targeted the WNT inhibitor SFRP2, which was enriched in fibrotic fibroblasts and acted as a TGF-\u03b2 target, leading to pathologic basal metaplasia of alveolar epithelial type 2 cells. The study highlights the epithelial-mesenchymal trophic unit as a key signaling hub in lung fibrosis, suggesting potential for future treatments targeting interconnected pathways like TGF-\u03b2 and WNT.", "population_specificity": "Patients with mild interstitial lung disease (ILD) who underwent EGCG treatment.", "effective_dosage": "Not available", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:47:03.951398+00:00"}
{"study_id": 12694, "supplement_id": 1110, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 80, "study_goal": "The researchers aimed to investigate the effects of EGCG on blood pressure and autonomic nervous system activity in obese subjects, as well as its correlations with metabolic factors.", "results_summary": "The 8-week EGCG treatment significantly reduced systolic, diastolic, and mean arterial blood pressure while increasing the LF/HF ratio, indicating a shift toward sympathetic dominance. EGCG also showed correlations with metabolic parameters, including positive associations with obesity markers and negative associations with insulin sensitivity and HDL-C.", "population_specificity": "Obese subjects (n=30)", "effective_dosage": "150 mg twice daily", "study_duration": "8 weeks", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:47:04.322386+00:00"}
{"study_id": 12695, "supplement_id": 1110, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 75, "study_goal": "The researchers aimed to investigate the inhibitory effects of Epigallocatechin Gallate (EGCg) on Bacillus anthracis spores and vegetative cells, as well as its potential to reduce the minimum inhibitory concentration of antibiotics for penicillin-resistant strains.", "results_summary": "EGCg inhibited the growth of vegetative B. anthracis cells but not spores. It also reduced the minimum inhibitory concentration of penicillin and meropenem for penicillin-resistant strains and decreased transcription levels of beta-lactamase genes.", "population_specificity": "Bacillus anthracis (spores and vegetative cells, including a penicillin-resistant strain)", "effective_dosage": "50 \u00b5g/mL EGCg", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:47:04.504846+00:00"}
{"study_id": 12697, "supplement_id": 1110, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 75, "study_goal": "The researchers aimed to determine whether epigallocatechin gallate (EGCG) could mitigate oleic acid-induced hepatic steatosis in primary chicken hepatocytes by modulating lipid synthesis, oxidative stress, inflammation, DNA damage, and apoptosis.", "results_summary": "EGCG effectively reduced lipid deposition by downregulating lipid synthesis-related genes, mitigated oxidative stress, inflammation, DNA damage, and apoptosis, and preserved hepatocyte viability by modulating the p38 MAPK signaling pathway.", "population_specificity": "Primary chicken hepatocytes (in vitro study).", "effective_dosage": "Not specified.", "study_duration": "Not specified.", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:47:07.148181+00:00"}
{"study_id": 12699, "supplement_id": 1110, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 78, "study_goal": "The researchers aimed to examine the therapeutic effects and underlying molecular mechanisms of EGCG on multiple myeloma (MM) cells.", "results_summary": "EGCG dose-dependently reduced cell viability and induced apoptosis in MM cell lines via activation of the ER stress pathway and disruption of cytoskeletal integrity. In vivo, EGCG inhibited myeloma tumor growth, an effect counteracted by the eIF2\u03b1 inhibitor ISRIB.", "population_specificity": "Multiple myeloma cell lines (MM.1S and RPMI 8226) and a mouse model.", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:47:07.654546+00:00"}
{"study_id": 12701, "supplement_id": 1110, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 75, "study_goal": "The researchers aimed to investigate the protective role of EGCG on high glucose-induced pancreatic beta cell dysfunction and its potential molecular mechanisms.", "results_summary": "EGCG dose-dependently restored mitochondrial membrane potential, reduced cell apoptosis, downregulated apoptotic protein BAX and DRP1, and upregulated anti-apoptotic protein BCL-2, suggesting it alleviates high glucose-induced beta cell dysfunction via the DRP1-related mitochondrial apoptosis pathway.", "population_specificity": "MIN6 cells (pancreatic beta cell line)", "effective_dosage": "10 \u00b5M, 20 \u00b5M, and 40 \u00b5M", "study_duration": "48 hours", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:47:11.721574+00:00"}
{"study_id": 12703, "supplement_id": 1110, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 75, "study_goal": "The researchers aimed to investigate whether Y6, an ethyl derivative of epigallocatechin gallate (EGCG), could reverse oxaliplatin resistance in hepatocellular carcinoma (HCC) cells.", "results_summary": "Y6 effectively reversed oxaliplatin resistance in HCC cells, inhibited proliferation, reduced invasion and migration, and modulated EMT-related proteins and the miR-338-3p/HIF-1\u03b1/Twist pathway, outperforming EGCG.", "population_specificity": "Oxaliplatin-resistant human liver cancer cells (SMMC-7721/OXA).", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:47:12.332434+00:00"}
{"study_id": 12700, "supplement_id": 1110, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 78, "study_goal": "The researchers aimed to explore the therapeutic effects and molecular mechanisms of EGCG in treating non-alcoholic fatty liver disease (NAFLD) using network pharmacology and animal experiments.", "results_summary": "EGCG improved body weight, glucolipid metabolism, steatosis, liver injury, insulin sensitivity, and glucose tolerance in NAFLD mice via the NLRP3-Caspase-1-GSDMD pyroptosis pathway. The study identified 266 common targets between EGCG, NAFLD, and pyroptosis, suggesting multi-target and multi-pathway efficacy.", "population_specificity": "NAFLD mice fed a high-fat diet (HFD).", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:47:12.619645+00:00"}
{"study_id": 12702, "supplement_id": 1110, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 75, "study_goal": "The researchers aimed to determine the effects of Epigallocatechin Gallate on non-small cell lung cancer cells (A549) in vitro, focusing on anti-proliferative activity and inhibition of cancer cell migration.", "results_summary": "Epigallocatechin Gallate demonstrated significant anti-proliferative effects on A549 cells in a concentration- and time-dependent manner, with an IC50 value of 60.55 \u00b1 1.0 \u03bcM. It also inhibited cell migration at concentrations near or above 50 \u03bcM.", "population_specificity": "A549 non-small cell lung cancer cell lines (in vitro).", "effective_dosage": "Concentrations near or above 50 \u03bcM (specific frequency not detailed).", "study_duration": "Not specified.", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:47:13.208653+00:00"}
{"study_id": 12706, "supplement_id": 1110, "safety_score": "85", "efficacy_score": 90, "quality_score": 80, "study_goal": "The researchers aimed to evaluate the anti-inflammatory effects and safety of EGCG when incorporated into an HA-BDDE hydrogel as a vitreous substitute post-vitrectomy.", "results_summary": "The study found that EGCG-enhanced hydrogel (HBE) reduced inflammatory gene expression in retinal pigment epithelial cells and improved postoperative outcomes in rabbits, including restored intraocular pressure and minimal inflammation.", "population_specificity": "New Zealand white rabbits undergoing vitreous substitution treatment.", "effective_dosage": "50 \u03bcM EGCG in the hydrogel (HBE 50).", "study_duration": "28 days post-surgery.", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:47:13.452241+00:00"}
{"study_id": 12705, "supplement_id": 1110, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 78, "study_goal": "The researchers aimed to identify compounds from Traditional Chinese Medicine that could inhibit Bcl-2 protein functionality, with a focus on Epigallocatechin gallate (EGCG), as a potential therapeutic for cancer and inflammatory conditions.", "results_summary": "The study found that EGCG effectively binds to Bcl-2, inhibiting its anti-apoptotic function, suggesting potential for treating malignancies and inflammatory diseases. Molecular dynamics simulations confirmed stable binding and favorable free energy interactions.", "population_specificity": "In silico (computer-based) study, no human or animal subjects.", "effective_dosage": "Not specified", "study_duration": "100 ns molecular dynamics simulation", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:47:13.698497+00:00"}
{"study_id": 12708, "supplement_id": 1110, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 75, "study_goal": "The researchers aimed to determine whether walnut isolate protein-epigallocatechin gallate (WPI-EGCG) nanoparticles could effectively encapsulate lycopene (LYC) and enhance its stability, antioxidant activity, and intracellular antioxidant enzyme restoration.", "results_summary": "The study found that WPI-EGCG nanoparticles successfully encapsulated lycopene, improving its stability under thermal, UV, and storage conditions while significantly enhancing antioxidant activity (lower EC50 value) and restoring intracellular antioxidant enzyme activities (SOD, CAT, GSH-Px) in HepG2 cells. Transcriptome analysis also indicated enrichment in glutathione metabolism and peroxisome processes.", "population_specificity": "HepG2 cells (human liver cancer cell line)", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:47:17.110853+00:00"}
{"study_id": 12707, "supplement_id": 1110, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 78, "study_goal": "The researchers aimed to determine whether EGCG could reduce liver fat content and protect against hepatic injury in NAFLD by inhibiting DPP4 expression and activity, and to identify potential clinical treatment strategies.", "results_summary": "EGCG suppressed lipid accumulation, inhibited inflammation, remediated dysregulated lipid metabolism, and improved NAFLD pathogenesis by inhibiting DPP4 expression and activity. The study highlights EGCG as a promising therapeutic option for NAFLD.", "population_specificity": "NAFLD patients (clinical trial) and male C57BL/6J mice fed a high-fat diet (animal model).", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:47:17.598108+00:00"}
{"study_id": 12712, "supplement_id": 1110, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 75, "study_goal": "The researchers aimed to determine how Epigallocatechin Gallate (EGCG) protects osteoblasts from cadmium-induced damage by examining its effects on cell viability, apoptosis, and differentiation.", "results_summary": "EGCG promoted the viability of cadmium-exposed osteoblasts, reduced apoptosis, and enhanced maturation and mineralization by upregulating the PI3K/AKT/mTOR and Nrf2/HO-1 signaling pathways.", "population_specificity": "MC3T3-E1 osteoblasts (a mouse cell line)", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:47:21.378492+00:00"}
{"study_id": 12711, "supplement_id": 1110, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 75, "study_goal": "The researchers aimed to explore the effect and potential regulatory mechanisms of EGCG in preeclampsia-like rats.", "results_summary": "EGCG reduced systolic blood pressure, improved kidney and liver markers, enhanced fetal growth, and alleviated inflammation and endothelial dysfunction in PE-like rats by modulating eNOS/Nrf2/HO-1 pathways and reducing ferroptosis.", "population_specificity": "Pregnant rats with induced preeclampsia-like symptoms.", "effective_dosage": "25 mg/kg (Low) or 50 mg/kg (High), administered orally.", "study_duration": "From gestational day 6 to 17.", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:47:21.442872+00:00"}
{"study_id": 12709, "supplement_id": 1110, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 75, "study_goal": "The researchers aimed to determine whether the combined use of l-Theanine and Epigallocatechin Gallate (EGCG) could more effectively alleviate alcoholic fatty liver in rats compared to their individual administration, and to explore the underlying mechanisms.", "results_summary": "The combination of LTA and EGCG significantly reduced liver damage markers (AST, ALT), hepatic fat accumulation, oxidative stress (MDA, ROS), and inflammation while enhancing antioxidant activity (SOD, glutathione peroxidase). The effects were attributed to modulation of lipid metabolism and oxidative stress pathways.", "population_specificity": "Sprague Dawley (SD) rats with induced alcoholic fatty liver.", "effective_dosage": "160 mg kg-1 day-1 EGCG (in combination with 40 mg kg-1 day-1 l-Theanine).", "study_duration": "6 weeks.", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:47:21.583026+00:00"}
{"study_id": 12713, "supplement_id": 1110, "safety_score": "Not Assessed", "efficacy_score": 75, "quality_score": 80, "study_goal": "The researchers aimed to investigate the potential of a nanoemulsified formulation combining EGCG with dolutegravir (DTG) for inhibiting HIV-1 replication and enhancing drug delivery.", "results_summary": "The study found that the dual drug-loaded nanoemulsion (NE-DTG-EGCG) demonstrated potential in inhibiting HIV-1 replication, with EGCG serving as a supplementary treatment. In silico studies highlighted EGCG's inhibitory effects on HIV-1 integrase and reverse transcriptase enzymes.", "population_specificity": "In vitro cellular, enzymatic, and molecular studies (no human or animal population specified).", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:47:22.484701+00:00"}
{"study_id": 12714, "supplement_id": 1110, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 75, "study_goal": "The researchers aimed to determine how partial gelatinization synergizing with epigallocatechin gallate (EGCG) affects the multi-scale structure and retrogradation properties of corn starch.", "results_summary": "The study found that partial gelatinization combined with EGCG significantly suppressed both short- and long-term retrogradation of corn starch, evidenced by reduced storage modulus, viscosity, crystallinity, and retrogradation degree. This effect was attributed to enhanced hydrogen bond interactions between starch molecules and EGCG.", "population_specificity": "Corn starch (in vitro study, no human or animal subjects)", "effective_dosage": "Not specified", "study_duration": "1 and 14 days (storage periods)", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:47:23.523337+00:00"}
{"study_id": 12715, "supplement_id": 1110, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 75, "study_goal": "The researchers aimed to enhance the oral bioavailability of epigallocatechin gallate by developing gastric pH-stable shellac nanoparticles and evaluate its therapeutic potential for diabetic nephropathy.", "results_summary": "The nanoparticle formulation (CESL-NP) improved kidney and pancreatic function in streptozotocin-treated mice, showing a 38.68-fold higher blood glucose level inhibition compared to free epigallocatechin gallate and curcumin. The nanoparticles demonstrated sustained release and stability under gastric pH conditions.", "population_specificity": "Streptozotocin-treated mice (diabetic nephropathy model)", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:47:25.743268+00:00"}
{"study_id": 12716, "supplement_id": 1110, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 75, "study_goal": "The researchers aimed to evaluate the effects of EGCG on the virulence of Streptococcus mutans biofilm development using a validated cariogenic model and clinically relevant treatment regimens.", "results_summary": "EGCG significantly reduced the accumulation of soluble and insoluble polysaccharides, altered the biofilm matrix structure, and disrupted the 3D organization of S. mutans biofilm, lowering its virulence without affecting bacterial viability or medium pH.", "population_specificity": "Streptococcus mutans biofilms (in vitro study)", "effective_dosage": "Clinically relevant treatment regimens, twice a day for 1.5 min (specific concentration not mentioned)", "study_duration": "Not specified (treatment frequency: twice a day)", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:47:27.539487+00:00"}
{"study_id": 12717, "supplement_id": 1110, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 75, "study_goal": "The researchers aimed to examine the impact of epigallocatechin gallate (EGCG) on cancer and cachexia symptoms in tumor-bearing mice fed a high-fat diet.", "results_summary": "EGCG demonstrated anti-cancer effects comparable to cisplatin while protecting against adipose tissue loss and muscle atrophy. It regulated lipolysis and browning factors in adipose tissue and reduced muscular atrophy markers, unlike cisplatin.", "population_specificity": "B16BL6 tumor-bearing mice fed a high-fat diet.", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:47:29.252720+00:00"}
{"study_id": 12719, "supplement_id": 1110, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 75, "study_goal": "The researchers aimed to summarize and highlight the effects of Epigallocatechin Gallate (EGCG) on cancer hallmarks, focusing on its potential as an anticancer therapeutic.", "results_summary": "EGCG demonstrated anti-proliferative, anti-angiogenic, and pro-apoptotic effects in cancer cell lines and animal models, interfering with cancer-related signaling pathways and hallmarks. The study suggests EGCG has substantial potential as an anticancer treatment.", "population_specificity": "Cancer cell lines and animal models (not specified further).", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:47:30.180380+00:00"}
{"study_id": 12710, "supplement_id": 1110, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 78, "study_goal": "The researchers aimed to explore the regulatory effects of EGCG on ferroptosis and its potential therapeutic implications for non-small cell lung cancer (NSCLC).", "results_summary": "EGCG suppressed NSCLC cell proliferation, modulated ferroptosis regulators (GPX4/SLC7A11 and ACSL4), increased intracellular iron, MDA, and ROS, and induced ferroptosis by downregulating tsRNA-13502.", "population_specificity": "Non-small cell lung cancer (NSCLC) cell lines.", "effective_dosage": "Varying concentrations (specific amounts not provided).", "study_duration": "Not specified.", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:47:31.191841+00:00"}
{"study_id": 12720, "supplement_id": 1110, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 75, "study_goal": "The researchers aimed to determine whether EGCG regulates hippocalcin expression and provides neuroprotective effects in ischemic stroke and glutamate-induced neuronal damage.", "results_summary": "EGCG treatment improved neurobehavioral deficits, reduced infarct volume, and mitigated decreases in hippocalcin expression in stroke models. It also alleviated neuronal cell death, calcium overload, and apoptotic markers in glutamate-exposed neurons.", "population_specificity": "Stroke animal model (MCAO) and glutamate-exposed neurons.", "effective_dosage": "50 mg/kg, injected once before MCAO surgery.", "study_duration": "Acute intervention (24-hour follow-up).", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:47:31.278796+00:00"}
{"study_id": 12718, "supplement_id": 1110, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 80, "study_goal": "The researchers aimed to determine whether Epigallocatechin Gallate (EGCG) inhibits adipogenesis and lipid accumulation by regulating the cell cycle during mitotic clonal expansion (MCE) and its underlying molecular mechanisms.", "results_summary": "EGCG significantly inhibited adipogenesis and lipid accumulation in 3T3-L1 cells and reduced obesity-related markers in mice by regulating cell cycle progression and inhibiting JAK2/STAT3 signaling. It also improved glucose intolerance and insulin sensitivity in high-fat diet-induced obese mice.", "population_specificity": "3T3-L1 preadipocytes and C57BL/6 mice fed a high-fat diet.", "effective_dosage": "25-100 \u03bcM in vitro; 50 or 100 mg/kg daily in vivo.", "study_duration": "9-24 hours in vitro; 3 months in vivo.", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:47:31.323990+00:00"}
{"study_id": 12722, "supplement_id": 1110, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 78, "study_goal": "The researchers aimed to summarize the effects of EGCG on tumor microenvironment, metabolic reprogramming, and anti-cancer immunotherapy.", "results_summary": "EGCG was found to promote anti-cancer immune responses, attenuate immunosuppression, inhibit tumor-promoting functions of various cells, and suppress metabolic reprogramming pathways. It also enhanced immunotherapeutic efficacy.", "population_specificity": "Not specified (general cancer research context)", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:47:34.189331+00:00"}
{"study_id": 12723, "supplement_id": 1110, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 75, "study_goal": "The researchers aimed to develop a green-synthesized photothermal therapy agent (EGCG-Fe complex nanoparticles) for enhanced antibacterial effects and wound healing.", "results_summary": "EGCG-Fe complex nanoparticles demonstrated improved stability, photothermal conversion ability, and effective antibacterial action against Gram-positive and Gram-negative bacteria, along with biofilm prevention and enhanced wound healing in a mice model.", "population_specificity": "Mice model (specific human population not mentioned).", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:47:35.802932+00:00"}
{"study_id": 12724, "supplement_id": 1110, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 78, "study_goal": "The researchers aimed to determine whether nanocomplexation of Epigallocatechin Gallate with hyaluronic acid could enhance the efficacy of the FLT3 inhibitor gilteritinib in treating FLT3-mutated acute myeloid leukemia.", "results_summary": "The nanocomplex improved gilteritinib's efficacy by enhancing cellular internalization via CD44 receptors, increasing reactive oxygen species and caspase-3/7 activity, and synergistically eradicating leukemic cells more effectively than free gilteritinib.", "population_specificity": "FLT3-mutated acute myeloid leukemia cells", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:47:38.373739+00:00"}
{"study_id": 12727, "supplement_id": 1110, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 75, "study_goal": "The researchers aimed to investigate the potential of Epigallocatechin gallate (EGCG) to treat neurodegenerative disorders caused by antiretroviral toxicity in HIV patients.", "results_summary": "EGCG partially restored neuronal damage, modulated inflammasome activity, improved antioxidant levels (SOD, GSH, CAT), reduced oxidative stress (MDA), and preserved brain architecture in HAART-treated rats.", "population_specificity": "Adult male Wistar rats (80-100g)", "effective_dosage": "2.5mg/kg", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:47:39.533977+00:00"}
{"study_id": 12725, "supplement_id": 1110, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 75, "study_goal": "The researchers aimed to evaluate the antibacterial and therapeutic potential of Epigallocatechin Gallate (EGCG) for treating periodontal disease in canines, based on its known effects in human periodontal disease.", "results_summary": "EGCG demonstrated significant antibacterial effects against key pathogens in canine periodontal disease, reduced microbial abundance in a mouse model, ameliorated bone loss, and down-regulated inflammatory markers like IL-6.", "population_specificity": "Canines with periodontal disease and a mouse model of periodontal disease.", "effective_dosage": "0.3125 mg/mL and 0.625 mg/mL (oral mucosal administration).", "study_duration": "7 days.", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:47:39.817412+00:00"}
{"study_id": 12728, "supplement_id": 1110, "safety_score": "Not Assessed", "efficacy_score": 75, "quality_score": 85, "study_goal": "The researchers aimed to determine whether EGCG from green tea extract could shrink fibroids, improve endometrial quality, and increase pregnancy likelihood in women with fibroids and unexplained infertility.", "results_summary": "The study is ongoing, but the hypothesis is that EGCG will reduce fibroid size and improve fertility outcomes, with primary and secondary outcomes including live birth rates, conception rates, and fibroid volume changes.", "population_specificity": "Reproductive-age women with uterine fibroids and unexplained infertility undergoing intrauterine insemination (IUI).", "effective_dosage": "1650 mg daily (green tea extract, with EGCG constituting approximately 45%).", "study_duration": "Up to four cycles of ovarian stimulation and timed IUI.", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:47:40.878954+00:00"}
{"study_id": 12721, "supplement_id": 1110, "safety_score": "85", "efficacy_score": 70, "quality_score": 60, "study_goal": "The researchers aimed to review the potential role of Epigallocatechin Gallate (EGCG) in preventing benign and malignant gynecologic disorders, focusing on its antioxidant, anticancer, and epigenetic regulatory properties.", "results_summary": "The study suggests EGCG has potential anticancer properties, inhibits cell division, stimulates apoptosis, and may help prevent benign reproductive disorders like uterine fibroids, endometriosis, and PCOS. However, the abstract does not provide specific clinical outcomes or statistical results.", "population_specificity": "Women with or at risk of gynecologic disorders (benign and malignant).", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:47:41.623677+00:00"}
{"study_id": 12729, "supplement_id": 1110, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 75, "study_goal": "The researchers aimed to evaluate the combined therapeutic effect of AFP-siRNA-loaded PLGA and epigallocatechin gallate (EGCG) on HepG2 cancer cells.", "results_summary": "The study found that EGCG and AFP-siRNA-PLGA co-treatment significantly reduced HepG2 cell viability to 59.73 \u00b1 6.95% and increased caspase-3/7 activity by 2.5-fold, indicating enhanced cytotoxicity and apoptosis compared to monotherapy.", "population_specificity": "HepG2 liver cancer cells (in vitro study).", "effective_dosage": "12.50 \u03bcg/mL of EGCG.", "study_duration": "Not specified.", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:47:44.608888+00:00"}
{"study_id": 12730, "supplement_id": 1110, "safety_score": "85", "efficacy_score": 80, "quality_score": 75, "study_goal": "The researchers aimed to assess the impact of EGCG combined with vitamin D and DCI on surgical outcomes and liver function in women with uterine fibroids undergoing laparoscopic myomectomy.", "results_summary": "The treatment significantly reduced surgery duration and blood loss while improving hemoglobin levels at discharge, without affecting liver function.", "population_specificity": "Non-pregnant or lactating women aged 30-40 years scheduled for laparoscopic myomectomy.", "effective_dosage": "300 mg EGCG, 50 \u03bcg vitamin D, and 50 mg DCI divided into 2 pills per day.", "study_duration": "3 months", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:47:45.568384+00:00"}
{"study_id": 12731, "supplement_id": 1110, "safety_score": "Not Assessed", "efficacy_score": 75, "quality_score": 65, "study_goal": "The researchers aimed to examine the interaction mechanism between epigallocatechin gallate (EGCG) and whey protein (WP) in a heat-treated aqueous solution system and hypothesize their binding characteristics.", "results_summary": "The study found that EGCG and WP exhibited static quenching, with increased binding constant and force at higher temperatures. The main binding modes were hydrophobic and electrostatic interactions, forming spontaneous complexes (\u0394G < 0) with approximately one binding site.", "population_specificity": "Not specified (in vitro study using EGCG and WP as raw materials).", "effective_dosage": "Not specified.", "study_duration": "Not specified.", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:47:46.928319+00:00"}
{"study_id": 12733, "supplement_id": 1110, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 75, "study_goal": "The researchers aimed to assess the efficacy of EGCG nanoparticles in treating Alzheimer's disease in rat/mouse models.", "results_summary": "EGCG nanoparticles showed significant potential in reducing AD pathology and improving cognitive deficits, with superior pharmacokinetics, BBB permeability, and brain bioavailability compared to free EGCG. They also effectively modulated oxidative stress and decreased AChE levels in AlCl3-treated rats.", "population_specificity": "Rat/mouse models of Alzheimer's disease.", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:47:47.318364+00:00"}
{"study_id": 12732, "supplement_id": 1110, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 75, "study_goal": "The researchers aimed to determine whether EGCG could counteract the detrimental effects of high-fat diet-induced obesity and rapamycin-induced reproductive and neuronal changes in rats.", "results_summary": "EGCG reversed rapamycin-exacerbated HFD-induced alterations in spermatogenesis, insulin-glucose balance, reproductive hormones, oxidative stress, and cognitive function. It also normalized serotonin, acetylcholinesterase levels, and autophagic and apoptotic activities in the testes and brains of rats.", "population_specificity": "Male rats with high-fat diet-induced obesity and rapamycin-induced reproductive and neuronal changes.", "effective_dosage": "80 mg/kg, orally administered.", "study_duration": "28 days (days 29-56 of the 56-day study).", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:47:49.517292+00:00"}
{"study_id": 12735, "supplement_id": 1110, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 75, "study_goal": "The researchers aimed to evaluate the anti-cancer effects of EGCG on ovarian cancer and explore its underlying molecular mechanisms.", "results_summary": "EGCG inhibited cell migration and survival, promoted apoptosis in ovarian cancer cells, and reduced tumor growth in a xenograft model. Mechanistically, EGCG activated FOXO3A and suppressed c-Myc expression.", "population_specificity": "Ovarian cancer cell lines (A2780 and SKOV3) and a xenograft animal model.", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:47:49.992309+00:00"}
{"study_id": 12734, "supplement_id": 1110, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 78, "study_goal": "The researchers aimed to determine whether EGCG modulates cardiac ischemia reperfusion-induced injury and elucidate its potential mechanisms via the MEG3/TAF15/AIM2 axis.", "results_summary": "EGCG improved cardiomyocyte viability and inhibited pyroptosis-related markers (AIM2, C-caspase-1, ASC, GSDMD-N, IL-18, IL-1\u03b2) in vitro and in vivo. MEG3 knockdown enhanced EGCG's therapeutic effects, while TAF15 overexpression reversed them.", "population_specificity": "Mice (in vivo) and HL-1 cells (in vitro)", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:47:50.276394+00:00"}
{"study_id": 12736, "supplement_id": 1110, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 75, "study_goal": "The researchers aimed to determine whether Epigallocatechin Gallate (EGCG) could reduce oxidative stress-mediated apoptosis in lens epithelial cells (LECs) and delay lens clouding in aged mice, while exploring the underlying mechanism involving RASSF2/AKT signaling.", "results_summary": "EGCG effectively reduced apoptosis in LECs and delayed lens clouding in aged mice. The study identified RASSF2 as a key gene mediating EGCG's effects, showing that it regulates AKT phosphorylation to inhibit apoptosis and ARCogenesis.", "population_specificity": "Aged mice and clinical samples (human lens tissues).", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:47:53.828548+00:00"}
{"study_id": 12737, "supplement_id": 1110, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 75, "study_goal": "The researchers aimed to investigate the role of EGCG in preventing dexamethasone-induced osteoporosis by examining its effects on intestinal microbiota and serum metabolites.", "results_summary": "EGCG inhibited bone density decline, improved bone microstructure, increased microbial diversity, promoted beneficial bacteria, and altered serum metabolites linked to bone health. These changes were associated with improved bone mineral density and structural parameters.", "population_specificity": "Not specified (likely animal or in vitro model based on context).", "effective_dosage": "Not provided.", "study_duration": "Not specified.", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:47:54.034639+00:00"}
{"study_id": 12738, "supplement_id": 1110, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 75, "study_goal": "The researchers aimed to determine the effects of EGCG on laying performance, immune status, antioxidant capacity, and hepatic metabolome in Linwu laying ducks under high-temperature conditions.", "results_summary": "EGCG increased egg production rate, improved immune function (higher immunoglobulin levels), enhanced antioxidant capacity (activated key enzymes), and modulated hepatic metabolites linked to metabolic pathways.", "population_specificity": "180 healthy 42-week-old Linwu laying ducks reared under high-temperature conditions.", "effective_dosage": "300 mg/kg dietary EGCG.", "study_duration": "21 days.", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:47:56.216397+00:00"}
{"study_id": 12739, "supplement_id": 1110, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 75, "study_goal": "The researchers aimed to determine if EGCG-modified silver nanoparticles (EGCG-AgNPs) could serve as an effective antiviral microbicide with adjuvant properties for treating herpes infections.", "results_summary": "EGCG-AgNPs significantly inhibited HSV-1 and HSV-2 attachment and entry in human keratinocytes compared to EGCG alone. In murine models, EGCG-AgNPs reduced virus titers and enhanced immune responses, including increased infiltration of immune cells and elevated cytokine expression.", "population_specificity": "Human HaCaT and VK-2-E6/E7 keratinocytes, and murine models of intranasal HSV-1 and genital HSV-2 infection.", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:47:56.353840+00:00"}
{"study_id": 12741, "supplement_id": 1110, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 75, "study_goal": "The researchers aimed to explore the regulatory effect of EGCG on oral microbial systems and its potential to alleviate oral inflammation in a mouse model.", "results_summary": "EGCG significantly ameliorated histological damage and reduced inflammatory cytokines (IL-6 and TNF-\u03b1) in acetic acid-induced oral inflammation. It also increased oral microbiota diversity and reversed microecological disorder.", "population_specificity": "Mouse model with acetic acid-induced oral inflammation.", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:47:57.918396+00:00"}
{"study_id": 12742, "supplement_id": 1110, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 75, "study_goal": "The researchers aimed to evaluate the efficacy of Epigallocatechin gallate (EGCG) in treating myocardial ischemia-reperfusion injury (MIRI) and summarize its underlying mechanisms.", "results_summary": "EGCG demonstrated a cardioprotective effect by reducing myocardial infarct size, improving cardiac function, and lowering serum myocardial injury enzyme and oxidative stress levels in MIRI animal models. The meta-analysis suggests therapeutic promise, though further validation in large animal models and clinical studies is needed.", "population_specificity": "Animal models (443 animals across 25 studies)", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:47:58.329938+00:00"}
{"study_id": 12743, "supplement_id": 1110, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 80, "study_goal": "The researchers aimed to determine whether combining EGFR-TKIs (gefitinib or osimertinib) with EGCG could overcome acquired drug resistance in NSCLC models by altering cancer metabolism and survival signaling.", "results_summary": "The combination of EGFR-TKIs and EGCG reversed the Warburg effect, suppressed glycolysis, boosted mitochondrial respiration, increased ROS, and decreased lactate secretion. It activated AMPK while inhibiting ERK/MAPK and AKT/mTOR pathways, leading to cell cycle arrest and apoptosis, particularly in resistant NSCLC cells, and effectively overcame osimertinib resistance in vivo.", "population_specificity": "EGFR-mutant NSCLC cell lines (parental and resistant) and xenograft mouse models derived from EGFR-TKI-resistant NSCLC cells.", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:48:00.359014+00:00"}
{"study_id": 12726, "supplement_id": 1110, "safety_score": "Not Assessed", "efficacy_score": 75, "quality_score": 65, "study_goal": "The researchers aimed to evaluate the impact of EGCG on cancer stem cells (CSCs), including its effects on cancer stemness signaling, apoptosis, metastasis, and therapy resistance.", "results_summary": "EGCG was found to reduce cancer stemness signaling and CSC biomarkers, induce apoptosis in CSCs, and inhibit EMT, metastasis, and therapy resistance. However, concerns about bioavailability and stability were noted, suggesting potential limitations in its efficacy without novel formulations or adjuvant therapies.", "population_specificity": "In vitro and in vivo cancer models (not specified further).", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:48:01.820064+00:00"}
{"study_id": 12744, "supplement_id": 1110, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 75, "study_goal": "The researchers aimed to develop new carriers (zeolites with divalent ions) to improve the stability and bioavailability of Epigallocatechin Gallate (EGCG) for treating osteoporosis and cancer.", "results_summary": "The study found that EGCG was effectively retained and released in a controlled manner from the proposed carriers, with release rates influenced by pH and the type of divalent ion used. The results suggest these carriers have significant potential and outperform existing options.", "population_specificity": "Not specified (in vitro or preclinical study implied).", "effective_dosage": "Not specified.", "study_duration": "Not specified.", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:48:01.918504+00:00"}
{"study_id": 12745, "supplement_id": 1110, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 78, "study_goal": "The researchers aimed to determine whether a bio-printed dermal scaffold loaded with Cu-EGCG could promote angiogenesis, reduce inflammation, and improve wound healing in diabetic wounds.", "results_summary": "The study found that the E/C hydrogel promoted angiogenesis, inhibited pro-inflammatory macrophage polarization, and improved wound healing in diabetic rats by modulating gene expression in the HIF-1\u03b1/VEGF and TNF-\u03b1/NF-\u03baB/MMP9 pathways.", "population_specificity": "Diabetic rats with full-thickness skin defects.", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:48:02.282022+00:00"}
{"study_id": 12746, "supplement_id": 1110, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 75, "study_goal": "The researchers aimed to evaluate the effectiveness of macrophage cell membrane-camouflaged nanoparticles (M-EC) assembled from EGCG and cerium(IV) ions in treating rheumatoid arthritis by targeting inflammation and oxidative stress.", "results_summary": "The M-EC nanoparticles effectively scavenged reactive oxygen and nitrogen species, accumulated at inflamed joints, and repaired bone erosion and cartilage damage in a collagen-induced arthritis mouse model. The treatment also relieved synovial inflammation and cartilage erosion.", "population_specificity": "Collagen-induced arthritis (CIA) mouse model", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:48:04.416134+00:00"}
{"study_id": 12747, "supplement_id": 1110, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 75, "study_goal": "The researchers aimed to determine whether the combination of EGCG and caffeine in green tea influences fat reduction, using C. elegans as a model organism.", "results_summary": "EGCG significantly reduced fat accumulation in C. elegans, as measured by Nile Red fluorescence intensity and triglyceride/protein ratio, while caffeine alone had no significant effect. The fat-reduction effect of EGCG + caffeine was comparable to EGCG alone, mediated by the regulation of lipogenesis-related genes (sbp-1, fat-7, daf-16).", "population_specificity": "Caenorhabditis elegans (nematode obesity model)", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:48:05.374279+00:00"}
{"study_id": 12748, "supplement_id": 1110, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 75, "study_goal": "The researchers aimed to summarize existing literature on the roles of Epigallocatechin Gallate (EGCG) in the chemoprophylaxis and therapy of hepatocellular carcinoma (HCC).", "results_summary": "EGCG was found to prevent and inhibit hepatic tumorigenesis and progression through multiple mechanisms, including effects on hepatitis virus infection, oxidative stress, proliferation, and apoptosis. It also enhanced the efficacy of chemotherapy, radiotherapy, and targeted therapy in HCC.", "population_specificity": "Preclinical studies under various experimental models and conditions (no specific human population mentioned).", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:48:06.114265+00:00"}
{"study_id": 12749, "supplement_id": 1110, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 75, "study_goal": "The researchers aimed to determine whether Epigallocatechin Gallate (EGCG) could protect germ cells from oxidative stress damage induced by MEHP.", "results_summary": "EGCG reduced MEHP-induced ROS overgeneration, suppressed the mTOR pathway, inhibited pyroptosis, and decreased apoptosis in germ cells. The findings suggest EGCG may be a potential treatment for MEHP-related spermatogenic dysfunction.", "population_specificity": "Spermatogonial cell line GC-1 and spermatocyte cell line GC-2 (in vitro study).", "effective_dosage": "60 \u03bcM EGCG.", "study_duration": "24 hours.", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:48:06.886243+00:00"}
{"study_id": 12750, "supplement_id": 1110, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 75, "study_goal": "The researchers aimed to determine whether postnatal EGCG treatment could mitigate cardiac dysfunction caused by prenatal alcohol exposure in mice.", "results_summary": "Postnatal EGCG therapy restored physiological levels of cardiac biomarkers (BNP, Hif1\u03b1, Nrf2, Bcl-2, Troponin I, glutathione peroxidase, Bax) and improved cardiac dysfunction (ejection fraction, left ventricle posterior wall thickness, Tei index) in mice prenatally exposed to alcohol.", "population_specificity": "C57BL/6J mice prenatally exposed to alcohol (Mediterranean or binge patterns).", "effective_dosage": "Not specified (EGCG-supplemented water).", "study_duration": "From birth to postnatal Day 60.", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:48:09.756434+00:00"}
{"study_id": 12751, "supplement_id": 1110, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 78, "study_goal": "The researchers aimed to analyze the antiallergic activities of epigallocatechin gallate (EGCG) and its effects on lipidome remodeling in mast cell degranulation.", "results_summary": "EGCG significantly inhibited mast cell degranulation by suppressing the release of \u03b2-hexosaminidase, interleukin-4, and tumor necrosis factor-\u03b1. Lipidomics revealed that EGCG disturbed lipid metabolism, with 78% of significant differential lipids upon IgE/antigen stimulation being regulated by EGCG.", "population_specificity": "Mast cell model (in vitro study)", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:48:10.882256+00:00"}
{"study_id": 12752, "supplement_id": 1110, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 80, "study_goal": "The researchers aimed to compare the efficacy of a moisturizer containing 5% EGCG alone versus 2% l-carnitine or their combination in controlling sebum production and improving skin hydration in individuals with seborrhea.", "results_summary": "The study found that the 5% EGCG group and the combination group showed significantly greater anti-sebum effects than the l-carnitine group, with all groups demonstrating significant improvements in sebum reduction, skin hydration, and subjective satisfaction.", "population_specificity": "90 subjects with seborrhea, divided into three groups.", "effective_dosage": "5% EGCG in moisturizing cream, applied topically (frequency not specified).", "study_duration": "4 weeks.", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:48:12.208816+00:00"}
{"study_id": 12753, "supplement_id": 1110, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 78, "study_goal": "The researchers aimed to investigate the impact of ultrasound-assisted free radical modification on the structure and functional properties of ovalbumin-epigallocatechin gallate (OVA-EGCG) conjugates.", "results_summary": "Ultrasound-assisted processing significantly improved conjugating efficiency and functional properties (emulsification and antioxidant capacity) of OVA-EGCG compared to traditional methods, with molecular docking supporting high-affinity binding.", "population_specificity": "Not specified (in vitro study).", "effective_dosage": "Not specified.", "study_duration": "1 hour (ultrasound-assisted) vs. 24 hours (traditional).", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:48:12.542202+00:00"}
{"study_id": 12754, "supplement_id": 1110, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 75, "study_goal": "The researchers aimed to determine whether combining epigallocatechin gallate with metformin and temozolomide could enhance therapeutic outcomes in a glioma-induced xenograft rat model.", "results_summary": "The triple-drug combination, including epigallocatechin gallate, significantly inhibited tumor growth, increased survival rates (50%), and induced apoptosis via ROS-mediated inactivation of the PI3K/AKT/mTOR pathway and cell cycle arrest.", "population_specificity": "Glioma-induced xenograft rat model", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "Concurrent administration with metformin and temozolomide was studied, but no specific interactions were detailed.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:48:13.497875+00:00"}
{"study_id": 12755, "supplement_id": 1110, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 78, "study_goal": "The researchers aimed to investigate the effect and mechanisms of epigallocatechin gallate (EGCG) on hepatic ferroptosis to mitigate hepatic injury in high-fat diet-fed mice.", "results_summary": "EGCG notably alleviated liver injury, lipid accumulation, oxidative stress, hepatic steatosis, and iron overload while inhibiting ferroptosis in high-fat diet-induced NAFLD mice. In vitro, EGCG reduced mitochondrial reactive oxygen species (MtROS) levels, thereby mitigating oxidative stress and ferroptosis in steatotic L-02 cells.", "population_specificity": "Male C57BL/6 mice and steatotic L-02 cells (human hepatocyte cell line).", "effective_dosage": "Not specified in the abstract.", "study_duration": "12 weeks.", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:48:15.285582+00:00"}
{"study_id": 12756, "supplement_id": 1110, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 78, "study_goal": "The researchers aimed to determine whether Epigallocatechin Gallate (EGCG) could inhibit DNA hypermethylation and tumor growth in head and neck squamous cell carcinoma (HNSCC).", "results_summary": "EGCG significantly reduced global DNA hypermethylation (70-80%) and DNMT activity (60-80%), reactivated tumor suppressors, and inhibited tumor growth by 80% in HNSCC xenografts.", "population_specificity": "HNSCC cell lines (FaDu and SCC-1) and nude mice with FaDu xenografts.", "effective_dosage": "0.5% (w/w) in AIN76A diet for in vivo study.", "study_duration": "6 days for in vitro, duration for in vivo not specified.", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:48:16.135601+00:00"}
{"study_id": 12757, "supplement_id": 1110, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 75, "study_goal": "To evaluate the effect of EGCG in preventing lens opacity and the aggregation of lens \u03b1B-crystallin in diabetic rat models.", "results_summary": "EGCG significantly lowered random blood sugar (RBS) and reduced lens opacity, with higher exposure increasing native lens \u03b1B-crystallin expression and decreasing aggregate expression. Each 1 mg/kg dose of EGCG increased native \u03b1B-crystallin by 0.0063 and decreased aggregates by 0.0076.", "population_specificity": "Wistar rats with diabetes mellitus (DM).", "effective_dosage": "300, 600, and 1200 mg/kg body weight.", "study_duration": "20 days.", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:48:16.208278+00:00"}
{"study_id": 55765, "supplement_id": 1110, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 75, "study_goal": "The researchers aimed to evaluate the therapeutic potential of EGCG in managing retinal diseases, focusing on its antioxidant, anti-inflammatory, and neuroprotective effects.", "results_summary": "EGCG demonstrated significant antioxidant, anti-inflammatory, and neuroprotective effects, making it a promising candidate for reducing oxidative stress and inflammation in ocular tissues, particularly in glaucoma, AMD, and diabetic retinopathy. The review consolidated preclinical and clinical studies supporting its adjunctive or alternative therapeutic use.", "population_specificity": "Patients with retinal diseases (glaucoma, age-related macular degeneration, diabetic retinopathy).", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:48:19.503172+00:00"}
{"study_id": 12759, "supplement_id": 1110, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 75, "study_goal": "The researchers aimed to determine whether epigallocatechin gallate (EGCG) could inhibit peritoneal fibrosis in peritoneal dialysis patients by affecting epithelial-mesenchymal transition (EMT) in human peritoneal mesothelial cells (HPMCs).", "results_summary": "EGCG effectively inhibited HPMC proliferation and migration, increased permeability, suppressed EMT markers (reducing \u03b1-SMA and FSP1 while enhancing Snail, E-cadherin, CK, and ZO-1), and delayed peritoneal fibrosis, with dose-dependent effects observed.", "population_specificity": "Human peritoneal mesothelial cells (HPMCs) from peritoneal dialysis patients.", "effective_dosage": "12.5, 25, 50, or 100 \u03bcmol/L EGCG.", "study_duration": "Not specified in the abstract.", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:48:20.455260+00:00"}
{"study_id": 55769, "supplement_id": 1110, "safety_score": "Not Assessed", "efficacy_score": null, "quality_score": null, "study_goal": "The researchers aimed to review mechanisms of protein-dependent neurodegeneration and current therapeutic approaches targeting protein misfolding and aggregation, without specific focus on Epigallocatechin Gallate.", "results_summary": "The abstract does not mention Epigallocatechin Gallate or its effects, focusing instead on general mechanisms and therapeutic strategies for neurodegenerative diseases.", "population_specificity": "Not specified (abstract discusses neurodegenerative disorders broadly).", "effective_dosage": "Not mentioned", "study_duration": "Not mentioned", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:48:21.372413+00:00"}
{"study_id": 55766, "supplement_id": 1110, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 75, "study_goal": "The researchers aimed to review recent findings on the therapeutic potential of Epigallocatechin Gallate (EGCG) in various human diseases, focusing on its molecular mechanisms and signaling pathways.", "results_summary": "EGCG exhibits antioxidant, anti-inflammatory, antibacterial, anticancer, and neuroprotective properties, with benefits for cardiovascular and oral health. It modulates key signaling pathways involved in neuronal survival, growth, and function, and regulates apoptosis and cell cycle progression, showing promise for treating metabolic diseases, cancer, and neurodegenerative disorders.", "population_specificity": "Not specified (review of existing research)", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:48:21.976698+00:00"}
{"study_id": 55767, "supplement_id": 1110, "safety_score": "Not Assessed", "efficacy_score": 75, "quality_score": 60, "study_goal": "The researchers aimed to evaluate the potential of Epigallocatechin Gallate as a therapeutic agent for Alzheimer's disease by examining its neuroprotective, antioxidant, anti-inflammatory, and cognitive-enhancing properties.", "results_summary": "The study found that Epigallocatechin Gallate demonstrated encouraging effects in modifying disease pathways associated with Alzheimer's, including neuroprotection, antioxidant activity, and anti-inflammatory properties. However, specific clinical outcomes or statistical significance were not detailed in the abstract.", "population_specificity": "Not specified (general focus on Alzheimer's disease)", "effective_dosage": "Not available", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:48:22.345998+00:00"}
{"study_id": 55770, "supplement_id": 1110, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 75, "study_goal": "The researchers aimed to evaluate the potential of nanoencapsulation to improve the stability, bioavailability, and therapeutic efficacy of EGCG in cancer treatment.", "results_summary": "Nanoencapsulation enhanced EGCG's physicochemical stability and pharmacokinetics, leading to improved therapeutic outcomes, including significant tumor growth inhibition in various models through targeted delivery and controlled release.", "population_specificity": "Cancer models (not specified if human or animal)", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:48:24.081310+00:00"}
{"study_id": 55775, "supplement_id": 1110, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 75, "study_goal": "The researchers aimed to review the anti-atherosclerosis effects of Epigallocatechin Gallate (EGCG) and its mechanisms, including lipid metabolism regulation, inflammation inhibition, and vascular protection.", "results_summary": "The study found that EGCG has multiple pharmacological effects, including regulating lipid metabolism, improving endothelial function, inhibiting inflammation, and reducing atherosclerosis-related morbidity and mortality. Various in vivo and ex vivo experiments supported its efficacy in preventing atherosclerosis and protecting cardiovascular health.", "population_specificity": "Not specified (general focus on atherosclerosis and cardiovascular disease prevention).", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:48:24.969306+00:00"}
{"study_id": 55773, "supplement_id": 1110, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 75, "study_goal": "The researchers aimed to summarize existing information on the relationship between EGCG and ferroptosis, focusing on its potential therapeutic effects in ferroptosis-related diseases.", "results_summary": "EGCG was found to improve ferroptosis-related diseases by regulating key signaling pathways, including nuclear factor erythroid 2-related factor 2, autophagy, microRNA, signal transducer and activator of transcription 1, and protein kinase D1. The study suggests EGCG has broad therapeutic potential in diseases linked to ferroptosis.", "population_specificity": "Not specified (literature review of existing studies)", "effective_dosage": "Not available", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:48:25.112152+00:00"}
{"study_id": 55778, "supplement_id": 1110, "safety_score": "Not Assessed", "efficacy_score": 70, "quality_score": 75, "study_goal": "The researchers aimed to explore the potential therapeutic role of epigallocatechin gallate in the treatment of uterine fibroids.", "results_summary": "Initial studies involving epigallocatechin gallate are encouraging, but additional research is required to establish its definitive therapeutic role in uterine fibroids.", "population_specificity": "Patients with uterine fibroids (specific demographics not detailed).", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:48:28.043563+00:00"}
{"study_id": 55776, "supplement_id": 1110, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 90, "study_goal": "The researchers aimed to investigate the effects of EGCG on TGF-\u03b21 signaling in lung fibroblasts and its potential therapeutic role in interstitial lung disease (ILD).", "results_summary": "EGCG downregulated TGF-\u03b21 signaling and proinflammatory pathways in biopsy samples, reduced fibroblast-secreted sFRP2, and mitigated IPF-related transcriptional changes, suggesting therapeutic potential for ILD.", "population_specificity": "Interstitial lung disease (ILD) patients undergoing diagnostic lung biopsy and nondiseased donors.", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:48:28.588204+00:00"}
{"study_id": 55780, "supplement_id": 1110, "safety_score": "Not Assessed", "efficacy_score": 75, "quality_score": 80, "study_goal": "The researchers aimed to explore whether bioactive components in green tea, particularly epigallocatechin gallate (EGCG), could mimic the anti-inflammatory effects of exercise in chronic diseases.", "results_summary": "The study suggests that EGCG has anti-inflammatory properties and may replicate some molecular-level benefits of exercise, though it does not provide specific clinical outcomes or direct comparisons to exercise effects.", "population_specificity": "Not specified (general focus on chronic inflammation in chronic diseases)", "effective_dosage": "Not provided", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:48:30.004619+00:00"}
{"study_id": 55781, "supplement_id": 1110, "safety_score": "Not Assessed", "efficacy_score": null, "quality_score": null, "study_goal": "The researchers aimed to explore the potential of epigallocatechin gallate (EGCG) as an emerging option for treating uterine fibroids.", "results_summary": "The abstract mentions ongoing research on EGCG but does not provide specific findings regarding its effects on uterine fibroids.", "population_specificity": "Reproductive-age women with symptomatic uterine fibroids.", "effective_dosage": "Not mentioned", "study_duration": "Not mentioned", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:48:30.007253+00:00"}
{"study_id": 55779, "supplement_id": 1110, "safety_score": "75", "efficacy_score": 80, "quality_score": 85, "study_goal": "The researchers aimed to elucidate the role of EGCG in modulating the oral-gut axis microbiota and its potential as a therapeutic strategy for inflammatory bowel disease (IBD).", "results_summary": "The study found that EGCG exhibits antibacterial properties, attenuates microbial translocation and colonization in the gut, and may alleviate IBD exacerbations. It also highlighted the need for improved bioavailability and proposed nano-delivery systems for enhanced efficacy.", "population_specificity": "Individuals with inflammatory bowel disease (IBD), including ulcerative colitis (UC) and Crohn's disease (CD).", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:48:30.444963+00:00"}
{"study_id": 55782, "supplement_id": 1110, "safety_score": "Not Assessed", "efficacy_score": null, "quality_score": 75, "study_goal": "The researchers aimed to explore the regulatory effects of natural products, including Epigallocatechin Gallate, on exosomal protein loading and their impact on tumor development.", "results_summary": "The abstract does not provide specific findings on Epigallocatechin Gallate but discusses the broader role of exosomal proteins in tumor growth and the potential influence of natural products on these processes.", "population_specificity": "Not specified (general focus on oncology and tumor microenvironment)", "effective_dosage": "Not provided", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:48:32.190123+00:00"}
{"study_id": 55784, "supplement_id": 1110, "safety_score": "Not Assessed", "efficacy_score": 75, "quality_score": 60, "study_goal": "The researchers aimed to evaluate the potential of flavonoids, including Epigallocatechin Gallate, in combating Hepatitis B Virus (HBV) infection by interfering with multiple stages of the HBV life cycle.", "results_summary": "Flavonoids demonstrated promising anti-HBV activities, suggesting their potential as novel antiviral agents. The abstract highlights their interference with multiple stages of the HBV life cycle but does not specify results for Epigallocatechin Gallate alone.", "population_specificity": "Not specified in the abstract.", "effective_dosage": "Not available.", "study_duration": "Not specified.", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:48:34.701345+00:00"}
{"study_id": 55792, "supplement_id": 1110, "safety_score": "Not Assessed", "efficacy_score": 75, "quality_score": 80, "study_goal": "The researchers aimed to explore the potential of Epigallocatechin Gallate (EGCG) as a therapeutic agent targeting altered signaling pathways in Alzheimer's disease (AD).", "results_summary": "The abstract suggests EGCG is in clinical trials for AD, targeting pathways like oxidative stress, neuroinflammation, and mitochondrial dysfunction, but specific efficacy results are not detailed.", "population_specificity": "Not specified (general AD context implied).", "effective_dosage": "Not mentioned.", "study_duration": "Not mentioned.", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:48:36.725278+00:00"}
{"study_id": 55793, "supplement_id": 1110, "safety_score": "Not Assessed", "efficacy_score": null, "quality_score": 75, "study_goal": "The researchers aimed to review the anti-inflammatory effects of dietary components, including Epigallocatechin Gallate, on mast cells and their potential role in allergy prevention and treatment.", "results_summary": "The abstract does not specifically mention Epigallocatechin Gallate's effects, focusing instead on other compounds like butyrate, calcitriol, and flavonoids.", "population_specificity": "Not specified (in vitro and in vivo models, general allergic disease population implied).", "effective_dosage": "Not mentioned", "study_duration": "Not mentioned", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:48:37.896094+00:00"}
{"study_id": 55794, "supplement_id": 1110, "safety_score": "Not Assessed", "efficacy_score": 75, "quality_score": 68, "study_goal": "The researchers aimed to summarize the anticancer effects of coffee constituents, including Epigallocatechin Gallate (EGCG), and their potential therapeutic use for oral squamous cell carcinoma (OSCC).", "results_summary": "EGCG demonstrated cytotoxic effects and influenced apoptotic mechanisms in cancer cell lines, with dose-dependent responses consistently observed. It was one of the most frequently studied constituents, showing anti-proliferative effects.", "population_specificity": "In vitro and in vivo models, including SCC25 cell lines and golden hamsters.", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:48:38.319354+00:00"}
{"study_id": 55795, "supplement_id": 1110, "safety_score": "Not Assessed", "efficacy_score": 75, "quality_score": 65, "study_goal": "The researchers aimed to evaluate the potential neuroprotective effects of green tea and its bioactive derivatives, including Epigallocatechin Gallate, against ischemic stroke.", "results_summary": "The study suggests that green tea's antioxidants, anti-inflammatory, anti-apoptotic, and neuroprotective properties may be efficacious in treating ischemic stroke, though it is a review rather than original research.", "population_specificity": "Not specified (general discussion of ischemic stroke patients).", "effective_dosage": "Not available", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:48:38.717646+00:00"}
{"study_id": 55796, "supplement_id": 1110, "safety_score": "Not Assessed", "efficacy_score": 75, "quality_score": 65, "study_goal": "The researchers aimed to review the anti-cancer mechanisms and potential therapeutic applications of tannins, including Epigallocatechin Gallate, focusing on chemoprevention, chemosensitization, and nanovehicle formation.", "results_summary": "The study highlights tannins' ability to target multiple cancer-related pathways, inhibit epithelial-to-mesenchymal transition, reduce cancer stem cell creation, and modulate cancer cell metabolism. It also discusses their potential as chemosensitizers and in drug delivery systems, though clinical trials are scarce.", "population_specificity": "Not specified (review of existing literature)", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:48:40.433658+00:00"}
{"study_id": 55797, "supplement_id": 1110, "safety_score": "Not Assessed", "efficacy_score": 75, "quality_score": 65, "study_goal": "The researchers aimed to explore the potential of dietary polyphenols, including Epigallocatechin Gallate, to slow aging and combat age-related diseases by targeting specific molecular and genetic pathways.", "results_summary": "The study suggests that Epigallocatechin Gallate and other polyphenols may slow aging and mitigate age-associated disorders by influencing pathways like oxidative stress, inflammation, and cellular signaling, with some clinical trials supporting these effects.", "population_specificity": "General aging population, particularly those with age-related diseases like diabetes, osteoporosis, cancer, and neurodegenerative disorders.", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:48:43.630112+00:00"}
{"study_id": 55798, "supplement_id": 1110, "safety_score": "Not Assessed", "efficacy_score": 75, "quality_score": 80, "study_goal": "The researchers aimed to summarize the biological properties of EGCG, particularly its potential role in cancer treatment and prevention.", "results_summary": "EGCG regulates multiple cellular signaling pathways involved in cancer, exhibiting anti-proliferative, anti-inflammatory, and apoptosis-inducing effects. Preclinical and clinical studies suggest its potential utility in treating various disorders, including cancer.", "population_specificity": "Not specified (general review of preclinical and clinical studies)", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:48:44.880870+00:00"}
{"study_id": 55791, "supplement_id": 1110, "safety_score": "Not Assessed", "efficacy_score": 75, "quality_score": 65, "study_goal": "The researchers aimed to explore the role of epigallocatechin gallate in targeting oxidative stress pathways (Nrf2 and CREB) to ameliorate Alzheimer's disease pathology.", "results_summary": "Epigallocatechin gallate was found to target Nrf2 and CREB pathways, leading to activation of downstream pathways like ARE and Keap1, which help reduce oxidative stress in Alzheimer's disease. The study suggests it may contribute to therapeutic advances by mitigating oxidative damage.", "population_specificity": "Not specified (general focus on Alzheimer's disease pathology)", "effective_dosage": "Not provided", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:48:45.526246+00:00"}
{"study_id": 55802, "supplement_id": 1110, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 75, "study_goal": "The researchers aimed to explore the neuroprotective potential of Epigallocatechin Gallate (EGCG) in modulating neuroimmune communication and its role in preventing or treating neuroinflammation, neurodegenerative diseases, and neurological damage.", "results_summary": "EGCG demonstrated neuroprotective effects by modulating autoimmune-related signals, improving neuroimmune communication, reducing inflammation, and promoting neuronal repair through neurotrophic factors and brain-gut axis mechanisms. It also improved intestinal microenvironmental homeostasis and ameliorated pathological phenotypes.", "population_specificity": "Not specified (general neurological disease context)", "effective_dosage": "Not provided", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:48:46.882872+00:00"}
{"study_id": 55800, "supplement_id": 1110, "safety_score": "Not Assessed", "efficacy_score": 75, "quality_score": 65, "study_goal": "The researchers aimed to determine whether epigallocatechin gallate can suppress STAT3 and its associated pathways to impede tumorigenesis in colorectal cancer.", "results_summary": "The study found that epigallocatechin gallate, along with other compounds, exhibits the ability to suppress STAT3 and its pathways, thereby hindering tumorigenesis in colorectal cancer. It also noted that STAT3 upregulation mediates resistance to certain anti-cancer drugs and reduces radio-sensitivity.", "population_specificity": "Colorectal cancer cells (in vitro or preclinical context, not specified for human subjects).", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:48:47.454284+00:00"}
{"study_id": 55803, "supplement_id": 1110, "safety_score": "Not Assessed", "efficacy_score": 70, "quality_score": 65, "study_goal": "The researchers aimed to explore the role of epigallocatechin gallate in modulating apoptotic pathways implicated in Alzheimer's disease.", "results_summary": "The study suggests epigallocatechin gallate targets apoptotic pathways, potentially restoring apoptotic balance and regulating key proteins involved in Alzheimer's disease, but specific efficacy data are not detailed.", "population_specificity": "Not specified (general focus on Alzheimer's disease pathology)", "effective_dosage": "Not provided", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:48:47.762114+00:00"}
{"study_id": 55804, "supplement_id": 1110, "safety_score": "Not Assessed", "efficacy_score": 75, "quality_score": 60, "study_goal": "The researchers aimed to review the role of phytoconstituents, including Epigallocatechin Gallate, in treating atopic dermatitis through cosmeceuticals.", "results_summary": "The abstract suggests Epigallocatechin Gallate has potential anti-inflammatory, antioxidant, and antibacterial effects beneficial for atopic dermatitis, with fewer side effects compared to synthetic preparations.", "population_specificity": "Not specified (general mention of atopic dermatitis patients).", "effective_dosage": "Not provided", "study_duration": "Not provided", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:48:52.176174+00:00"}
{"study_id": 55788, "supplement_id": 1110, "safety_score": "Not Assessed", "efficacy_score": 75, "quality_score": 65, "study_goal": "The researchers aimed to summarize the modifying effect of EGCG on miRNAs in cancer and discuss its anticancer mechanisms.", "results_summary": "EGCG exhibits anti-proliferative, anti-mutagenic, anti-inflammatory, and antioxidative properties, influencing dysregulated miRNAs in cancer to modulate proliferative signaling, cell death, invasiveness, metastasis, and angiogenesis. The study highlights EGCG's potential in cancer chemotherapy but does not provide specific clinical outcomes.", "population_specificity": "Pre-clinical cell culture and animal model systems (not human subjects).", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:48:52.871551+00:00"}
{"study_id": 55805, "supplement_id": 1110, "safety_score": "Not Assessed", "efficacy_score": 50, "quality_score": 60, "study_goal": "The researchers aimed to identify Epigallocatechin Gallate as a potential add-on drug for asthma due to its anti-VEGF properties.", "results_summary": "The study listed Epigallocatechin Gallate among putative add-on drugs for asthma with anti-VEGF effects, but no specific results or clinical data were provided regarding its efficacy. Further studies and clinical trials were recommended to evaluate its effectiveness.", "population_specificity": "Not specified (general asthma population implied).", "effective_dosage": "Not mentioned.", "study_duration": "Not mentioned.", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:48:53.505602+00:00"}
{"study_id": 55806, "supplement_id": 1110, "safety_score": "Not Assessed", "efficacy_score": 70, "quality_score": 80, "study_goal": "The researchers aimed to examine the molecular mechanisms underlying the protective effects of polyphenols, including Epigallocatechin Gallate, in multiple sclerosis (MS) and review clinical evidence for their use as adjuvant therapy.", "results_summary": "The abstract highlights that Epigallocatechin Gallate has shown potential as an adjuvant therapy in MS due to its anti-inflammatory and antioxidant effects, though clinical evidence is limited compared to other polyphenols like curcumin.", "population_specificity": "Multiple sclerosis patients (clinical trial mentioned in the abstract).", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:48:53.692199+00:00"}
{"study_id": 55809, "supplement_id": 1110, "safety_score": "Not Assessed", "efficacy_score": 70, "quality_score": 60, "study_goal": "The researchers aimed to explore the role of Epigallocatechin Gallate (EGCG) as an indirect-acting drug targeting NLRP3 inflammasome in the treatment of diabetic bone disorders.", "results_summary": "EGCG was identified as an indirect-acting drug that targets NLRP3 inflammasome, potentially mitigating hyperglycemia-induced bone formation impairment in diabetic patients. The abstract does not provide specific efficacy data for EGCG but includes it among promising therapeutic candidates.", "population_specificity": "Diabetic patients with bone disorders.", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:48:55.781588+00:00"}
{"study_id": 55808, "supplement_id": 1110, "safety_score": "Not Assessed", "efficacy_score": 65, "quality_score": 70, "study_goal": "The researchers aimed to review the potential of flavonoids, including Epigallocatechin Gallate (EGCG), in treating COVID-19 by examining their antiviral activities and pharmacological effects.", "results_summary": "The study found that EGCG, among other flavonoids, exhibits antiviral properties such as inhibiting SARS-CoV-2 invasion, replication, and viral proteases, as well as modulating interferon and proinflammatory factors. However, most research remains theoretical, requiring further studies to confirm efficacy and safety.", "population_specificity": "Not specified (general review of existing literature)", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:48:55.785822+00:00"}
{"study_id": 55810, "supplement_id": 1110, "safety_score": "Not Assessed", "efficacy_score": 75, "quality_score": 60, "study_goal": "The researchers aimed to identify natural products, including Epigallocatechin Gallate, that exhibit inhibitory effects on different stages of the Zika virus lifecycle.", "results_summary": "Epigallocatechin Gallate was found to inhibit viral entry by targeting the ZIKV E protein and also inhibited NS2B-NS3 protease activity, thereby hampering viral replication. It was one of the few compounds that could arrest both viral entry and replication.", "population_specificity": "In vitro studies (no specific human or animal population mentioned).", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:48:56.067963+00:00"}
{"study_id": 55799, "supplement_id": 1110, "safety_score": "Not Assessed", "efficacy_score": 65, "quality_score": 70, "study_goal": "The researchers aimed to evaluate the potential beneficial effects of epigallocatechin gallate (EGCG) and other polyphenols on endometriosis, focusing on their role in supporting or complementing traditional treatments.", "results_summary": "The study suggests that EGCG and other polyphenols may have positive effects on the development and course of endometriosis, but most evidence comes from animal models, with limited data on human efficacy.", "population_specificity": "Women of reproductive age with endometriosis (primarily studied in animal models).", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:48:58.078491+00:00"}
{"study_id": 55811, "supplement_id": 1110, "safety_score": "Not Assessed", "efficacy_score": 50, "quality_score": 60, "study_goal": "The researchers aimed to explore the potential role of epigallocatechin gallate as a natural bioactive product in preventing kidney stone disease.", "results_summary": "The abstract mentions epigallocatechin gallate as one of several natural bioactive products discussed for kidney stone prevention, but no specific results or efficacy data are provided.", "population_specificity": "Not specified (general discussion on kidney stone prevention strategies).", "effective_dosage": "Not provided", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:49:00.944938+00:00"}
{"study_id": 55812, "supplement_id": 1110, "safety_score": "Not Assessed", "efficacy_score": 75, "quality_score": 80, "study_goal": "The researchers aimed to review the absorption, metabolism, and biotransformation of EGCG, focusing on its interactions with gut microbiota and potential disease-preventive and therapeutic properties.", "results_summary": "The study highlights EGCG's bioactivities, including antioxidant, anti-inflammatory, anti-cancer, and antibacterial effects, but notes its poor bioavailability. It discusses metabolic interactions with gut microbiota and the potential of its metabolites for improving gut microbiota and physiological health.", "population_specificity": "Not specified (review article)", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:49:01.051077+00:00"}
{"study_id": 55813, "supplement_id": 1110, "safety_score": "Not Assessed", "efficacy_score": 75, "quality_score": 70, "study_goal": "The researchers aimed to determine whether acute ingestion of epigallocatechin gallate (EGCG) influences catecholamine metabolism during graded cycle exercise in humans.", "results_summary": "Acute EGCG supplementation reduced circulating catecholamines during exercise but did not affect metanephrine, glucose, or lactate levels. The lower catecholamine levels may explain a reduced lipid oxidation rate.", "population_specificity": "Eight males (22.4 \u00b1 3.3 years, BMI: 25.7 \u00b1 2.4 kg/m\u00b2).", "effective_dosage": "Not specified in the abstract.", "study_duration": "Acute (single-dose intervention).", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:49:02.199908+00:00"}
{"study_id": 55815, "supplement_id": 1110, "safety_score": "Not Assessed", "efficacy_score": null, "quality_score": null, "study_goal": "The researchers aimed to summarize and analyze molecular mechanistic and clinical studies on the activities of gut microbial metabolites and natural medicines, including Epigallocatechin Gallate, against carcinogenic viruses, particularly EBV.", "results_summary": "The abstract does not provide specific findings on Epigallocatechin Gallate's effects, focusing instead on broader categories like gut microbial metabolites and natural products.", "population_specificity": "Not specified (general focus on carcinogenic viruses, particularly EBV).", "effective_dosage": "Not mentioned", "study_duration": "Not mentioned", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:49:03.667923+00:00"}
{"study_id": 55816, "supplement_id": 1110, "safety_score": "Not Assessed", "efficacy_score": null, "quality_score": null, "study_goal": "The researchers aimed to evaluate the potential of natural compounds, including Epigallocatechin Gallate, to target the PI3K/AKT pathway for obesity management.", "results_summary": "The abstract discusses the role of PI3K/AKT signaling in obesity and highlights preclinical studies on plant secondary metabolites, but specific findings on Epigallocatechin Gallate are not detailed.", "population_specificity": "Not specified (preclinical studies referenced, but no human or animal details provided).", "effective_dosage": "Not mentioned", "study_duration": "Not mentioned", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:49:03.756746+00:00"}
{"study_id": 55814, "supplement_id": 1110, "safety_score": "90", "efficacy_score": 70, "quality_score": 85, "study_goal": "The researchers aimed to assess the safety of EGCG alone or in combination with ovarian stimulators (clomiphene citrate or letrozole) in premenopausal women, focusing on liver function and folate levels.", "results_summary": "The study found that 800 mg of EGCG daily, alone or combined with clomiphene citrate or letrozole, was well-tolerated with no liver toxicity or folate deficiency observed. No adverse effects were reported.", "population_specificity": "Premenopausal women aged 18-40, with or without uterine fibroids.", "effective_dosage": "800 mg of EGCG daily, alone or with 100 mg clomiphene citrate for 5 days or 5 mg letrozole for 5 days.", "study_duration": "Not explicitly stated, but ovarian stimulators were administered for 5 days.", "interactions": "None mentioned beyond the tested combinations with clomiphene citrate and letrozole.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:49:04.297870+00:00"}
{"study_id": 55818, "supplement_id": 1110, "safety_score": "Not Assessed", "efficacy_score": 75, "quality_score": 80, "study_goal": "The researchers aimed to evaluate the potential of nanogold-based carriers containing EGCG to enhance its chemotherapeutic effects in cancer treatment.", "results_summary": "The study found that nanoscale delivery of EGCG improved its solubility and bioavailability, potentially overcoming cellular barriers and enhancing its anticancer effects, both individually and in combination therapy.", "population_specificity": "Not specified (focused on in vitro or preclinical applications).", "effective_dosage": "Not specified.", "study_duration": "Not specified.", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:49:05.589154+00:00"}
{"study_id": 55819, "supplement_id": 1110, "safety_score": "Not Assessed", "efficacy_score": 65, "quality_score": 70, "study_goal": "The researchers aimed to evaluate the anti-inflammatory properties of tea and coffee, including Epigallocatechin Gallate, and their potential role in reducing cardiovascular risk.", "results_summary": "The study found inconsistent results regarding the anti-inflammatory effects of tea and coffee, though they may increase adiponectin, reduce reactive oxygen species, and lower LDL cholesterol. The clinical significance of these effects remains uncertain due to confounding factors.", "population_specificity": "General population, with a focus on cardiovascular risk factors.", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:49:09.116746+00:00"}
{"study_id": 55821, "supplement_id": 1110, "safety_score": "85", "efficacy_score": 90, "quality_score": 88, "study_goal": "The researchers aimed to determine whether catechins, particularly Epigallocatechin Gallate (EGCG), could mitigate acrylamide-induced toxicity and improve metabolic disorders.", "results_summary": "EGCG supplementation promoted the excretion of acrylamide metabolites, attenuated hemoglobin adduct ratios, and improved metabolic disorders related to glycolipid and energy metabolism. It also reduced cardiometabolic risk by mediating phenylalanine metabolism.", "population_specificity": "65 adults and acrylamide-exposed rats.", "effective_dosage": "200 mg, 100 mg, or 50 mg TP (tea polyphenols).", "study_duration": "Not specified in the abstract.", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:49:10.889554+00:00"}
{"study_id": 55820, "supplement_id": 1110, "safety_score": "Not Assessed", "efficacy_score": null, "quality_score": null, "study_goal": "The researchers were attempting to determine the potential role of Epigallocatechin Gallate in addressing neurodegenerative diseases characterized by protein accumulation and associated biological responses.", "results_summary": "The abstract does not provide specific findings regarding Epigallocatechin Gallate's effects, only mentioning its potential in the context of neurodegenerative disease research.", "population_specificity": "Not specified in the abstract.", "effective_dosage": "Not provided.", "study_duration": "Not specified.", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:49:11.499601+00:00"}
{"study_id": 55825, "supplement_id": 1110, "safety_score": "Not Assessed", "efficacy_score": 75, "quality_score": 80, "study_goal": "The researchers aimed to review the wound-healing effects of Mediterranean medicinal plants and polyphenolic compounds, including Epigallocatechin Gallate.", "results_summary": "The study identified Epigallocatechin Gallate as one of the main phenolic compounds demonstrating wound-healing effects, alongside other polyphenols. The abstract suggests these compounds provide therapeutic evidence for wound healing and potential drug development.", "population_specificity": "Not specified (general review of Mediterranean medicinal plants and polyphenolic compounds).", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:49:11.575795+00:00"}
{"study_id": 55824, "supplement_id": 1110, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 75, "study_goal": "The researchers aimed to evaluate the potential of flavonoids, including Epigallocatechin Gallate (EGCG), to mitigate cellular senescence and delay ageing-related diseases.", "results_summary": "The study found that EGCG, among other flavonoids, exhibits potent antisenescence effects, potentially modulating cellular senescence processes or interacting with molecular targets related to ageing pathways. The abstract suggests flavonoids could be promising senotherapeutics, though specific mechanisms and outcomes for EGCG require further investigation.", "population_specificity": "Not specified (general focus on ageing-related cellular senescence)", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:49:12.341425+00:00"}
{"study_id": 55826, "supplement_id": 1110, "safety_score": "85", "efficacy_score": 20, "quality_score": 75, "study_goal": "The researchers aimed to evaluate the safety, tolerability, and efficacy of EGCG in improving cognitive and functional performance in children with Down syndrome.", "results_summary": "EGCG was found to be safe and well-tolerated, with no severe adverse events, but it did not improve cognition or functionality compared to placebo. Secondary outcomes suggested potential efficacy in girls, warranting further research.", "population_specificity": "Children with Down syndrome aged 6-12 years.", "effective_dosage": "10 mg/kg daily dose (0.5% EGCG).", "study_duration": "6 months of treatment with 3 months of follow-up.", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:49:13.181835+00:00"}
{"study_id": 55827, "supplement_id": 1110, "safety_score": "Not Assessed", "efficacy_score": 75, "quality_score": 80, "study_goal": "The researchers aimed to review clinical evidence on the beneficial effects of EGCG supplementation in obese subjects and patients with metabolic complications like type 2 diabetes and cardiovascular disease.", "results_summary": "The study found that EGCG demonstrated strong antioxidant and anti-inflammatory properties, potentially protecting against metabolic syndrome. It also highlighted EGCG's potential as a nutraceutical and discussed its pharmaceutical development, including bioavailability and metabolism.", "population_specificity": "Obese subjects and patients with metabolic complications (e.g., type 2 diabetes, cardiovascular disease).", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:49:14.176930+00:00"}
{"study_id": 55828, "supplement_id": 1110, "safety_score": "Not Assessed", "efficacy_score": 75, "quality_score": 80, "study_goal": "The researchers explored the use of fucoidan-based nanoparticles for delivering Epigallocatechin Gallate in cancer therapies.", "results_summary": "The study found that fucoidan nanoparticles effectively delivered Epigallocatechin Gallate for cancer therapies, demonstrating potential in drug delivery applications. No specific efficacy metrics or clinical outcomes for Epigallocatechin Gallate were detailed.", "population_specificity": "Not specified (general biomedical applications).", "effective_dosage": "Not specified.", "study_duration": "Not specified.", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:49:16.576076+00:00"}
{"study_id": 55829, "supplement_id": 1110, "safety_score": "Not Assessed", "efficacy_score": null, "quality_score": null, "study_goal": "The researchers aimed to explore the potential of natural compounds, including Epigallocatechin Gallate, as complementary treatments for breast cancer.", "results_summary": "The abstract does not provide specific findings on Epigallocatechin Gallate's effects.", "population_specificity": "Not specified in the abstract.", "effective_dosage": "Not provided.", "study_duration": "Not specified.", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:49:18.009061+00:00"}
{"study_id": 55817, "supplement_id": 1110, "safety_score": "Not Assessed", "efficacy_score": 75, "quality_score": 65, "study_goal": "The researchers aimed to review the anticancer effects of phytochemicals, including Epigallocatechin Gallate (EGCG), and examine their role in regulating molecular pathways linked to cancer development and spread.", "results_summary": "The study highlights EGCG as a phytochemical with potential anticancer effects, including regulating molecular pathways, enhancing antioxidant status, and suppressing cancer proliferation. However, specific results or clinical outcomes for EGCG are not detailed in the abstract.", "population_specificity": "Not specified (general review of phytochemicals in cancer treatment).", "effective_dosage": "Not mentioned", "study_duration": "Not mentioned", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:49:18.975449+00:00"}
{"study_id": 55832, "supplement_id": 1110, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 75, "study_goal": "The researchers aimed to review evidence on how EGCG modulates autophagy and exerts anti-cancer effects in experimental cancer models.", "results_summary": "EGCG promotes cytotoxic autophagy, often by inactivating the PI3K/Akt/mTOR pathway, leading to apoptosis. It also inhibits cell growth and pro-survival autophagy when combined with chemotherapy drugs.", "population_specificity": "Experimental cancer models (in vitro or animal studies, not specified further).", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:49:20.499855+00:00"}
{"study_id": 55830, "supplement_id": 1110, "safety_score": "Not Assessed", "efficacy_score": 65, "quality_score": 75, "study_goal": "The researchers aimed to evaluate whether polyphenol-rich compounds like Epigallocatechin Gallate (EGCG) can delay or reverse cardiac aging and prevent cardiovascular disease in humans, with a focus on gender-related differences.", "results_summary": "The abstract suggests that EGCG, as a caloric restriction-mimetic, may extend health-span and induce autophagy, potentially retarding cardiac aging in animals and preventing CVD in humans, though specific results for EGCG are not detailed.", "population_specificity": "Aged human hearts, with consideration of gender-related differences in cardiac response.", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:49:20.569554+00:00"}
{"study_id": 55831, "supplement_id": 1110, "safety_score": "Not Assessed", "efficacy_score": 65, "quality_score": 75, "study_goal": "The researchers aimed to review the effects of EGCG on Parkinson's disease (PD) models, explore potential neuroprotective mechanisms, and summarize recent clinical trials in human PD.", "results_summary": "The abstract suggests EGCG may delay neurodegeneration in PD, but current results show little evidence for its use in preventing or treating central nervous system diseases. The review highlights the need for further investigation into nutraceuticals like EGCG.", "population_specificity": "Animal models and human PD patients (clinical trials).", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:49:21.230626+00:00"}
{"study_id": 55833, "supplement_id": 1110, "safety_score": "Not Assessed", "efficacy_score": 75, "quality_score": 65, "study_goal": "The researchers aimed to summarize the effects of polyphenols, including Epigallocatechin Gallate (EGCG), on reducing the allergenicity of allergenic proteins and explore the underlying mechanisms.", "results_summary": "Polyphenols like EGCG were found to reduce allergenicity by inducing structural changes in allergens, masking or destroying epitopes, and modulating immune responses in murine models. The effects varied based on polyphenol type, concentration, and other factors.", "population_specificity": "Murine models (mice)", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:49:21.363114+00:00"}
{"study_id": 55835, "supplement_id": 1110, "safety_score": "85", "efficacy_score": 75, "quality_score": 80, "study_goal": "The researchers aimed to evaluate the safety and metabolic effects of Epigallocatechin Gallate (EGCG) as part of a review on weight management dietary supplements.", "results_summary": "EGCG was found to be generally safe when used as directed, with serious adverse events being rare and typically linked to unusually high intakes. It also improved markers of metabolic health, such as glucose and lipids, though data for some effects were limited.", "population_specificity": "Overweight and obese individuals.", "effective_dosage": "Not specified (within manufacturers' recommended limits).", "study_duration": "Not specified.", "interactions": "Potential interactions with concomitant medications/supplements were noted, though specifics were not provided.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:49:23.291240+00:00"}
{"study_id": 55836, "supplement_id": 1110, "safety_score": "Not Assessed", "efficacy_score": 75, "quality_score": 65, "study_goal": "The researchers aimed to evaluate the potential of Epigallocatechin Gallate as a senotherapeutic agent for cancer treatment by inducing cellular senescence.", "results_summary": "The study identified Epigallocatechin Gallate as a promising natural product with senotherapeutic properties, capable of inhibiting cancer efficiently, though specific efficacy data were not detailed in the abstract.", "population_specificity": "Not specified in the abstract.", "effective_dosage": "Not specified in the abstract.", "study_duration": "Not specified in the abstract.", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:49:24.580560+00:00"}
{"study_id": 55837, "supplement_id": 1110, "safety_score": "Not Assessed", "efficacy_score": 65, "quality_score": 75, "study_goal": "The researchers aimed to evaluate the adjunctive effect of EGCG aqueous solution as a coolant during scaling and root planing in managing chronic periodontitis.", "results_summary": "EGCG solution improved the bleeding index significantly at 12 weeks but showed no additional benefit for other clinical parameters like probing depth, clinical attachment level, gingival index, and plaque index compared to water.", "population_specificity": "15 patients with moderate to severe chronic periodontitis.", "effective_dosage": "5 mg/mL EGCG solution used as an irrigant during periodontal therapy.", "study_duration": "12 weeks (measurements taken at baseline, 6 weeks, and 12 weeks).", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:49:26.705939+00:00"}
{"study_id": 55838, "supplement_id": 1110, "safety_score": "Not Assessed", "efficacy_score": 70, "quality_score": 75, "study_goal": "The researchers aimed to evaluate the effects of green tea supplementation, particularly Epigallocatechin Gallate, on weight and metabolic parameters in women with PCOS.", "results_summary": "Green tea supplementation significantly reduced body weight in women with PCOS, with a mean difference of -2.80 kg compared to placebo. The evidence was of very low quality, suggesting potential positive effects but requiring further confirmation.", "population_specificity": "Women with polycystic ovary syndrome (PCOS)", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:49:28.090153+00:00"}
{"study_id": 55839, "supplement_id": 1110, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 75, "study_goal": "The researchers aimed to review factors affecting the bioavailability of EGCG and explore strategies to enhance its stability, bioavailability, and therapeutic efficacy for clinical and functional food applications.", "results_summary": "The study found that EGCG has multiple health-promoting effects but suffers from low stability and bioavailability. Structural modifications and nanoparticle-based delivery systems (e.g., nano-emulsions, silica-based nanoparticles) were identified as effective strategies to improve its absorption and therapeutic potential.", "population_specificity": "Not specified (review paper, not a clinical study)", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:49:29.161540+00:00"}
{"study_id": 55842, "supplement_id": 1110, "safety_score": "Not Assessed", "efficacy_score": 75, "quality_score": 80, "study_goal": "The researchers aimed to examine the role of epigallocatechin gallate (EGCG) in attenuating inflammatory markers associated with chronic diseases.", "results_summary": "The abstract indicates that EGCG, among other natural products, may help lower inflammation linked to chronic diseases like obesity, diabetes, cardiovascular diseases, and cancer, but specific findings on EGCG are not detailed.", "population_specificity": "Not specified (general discussion of chronic disease populations).", "effective_dosage": "Not provided.", "study_duration": "Not specified.", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:49:29.326348+00:00"}
{"study_id": 55841, "supplement_id": 1110, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 75, "study_goal": "The researchers aimed to assess the effects of epigallocatechin gallate on neuropathic pain and related neuroinflammation.", "results_summary": "Epigallocatechin gallate demonstrated anti-neuropathic pain effects by reducing mechanical allodynia, hyperalgesia, and cold hyperalgesia in animal studies, likely through suppression of NF-\u03baB and MAPK signaling pathways and modulation of neuronal excitability.", "population_specificity": "Animal models of neuropathic pain (specific species not mentioned).", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:49:29.362720+00:00"}
{"study_id": 55840, "supplement_id": 1110, "safety_score": "Not Assessed", "efficacy_score": 65, "quality_score": 70, "study_goal": "The researchers aimed to evaluate the potential of natural dietary compounds, including Epigallocatechin Gallate, as chemotherapeutics for glioblastoma by examining their anti-glioblastoma effects and challenges like bioavailability and blood-brain barrier permeability.", "results_summary": "The study suggests that natural compounds, including Epigallocatechin Gallate, may have anti-glioblastoma effects through mechanisms like apoptosis upregulation, autophagy, and inhibition of angiogenesis and metastasis, but their efficacy is limited by bioavailability and blood-brain barrier permeability.", "population_specificity": "Glioblastoma patients (theoretical, based on in vitro and in vivo studies)", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:49:29.366606+00:00"}
{"study_id": 55843, "supplement_id": 1110, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 75, "study_goal": "The researchers aimed to review the pharmacological features of EGCG and its therapeutic implications in cancer and other metabolic diseases, focusing on its anti-cancer, anti-inflammatory, and anti-oxidant effects.", "results_summary": "EGCG demonstrated strong anti-cancer properties by modulating signaling pathways, inhibiting tumor cell survival and proliferation, and inducing apoptosis. It also showed anti-inflammatory, anti-angiogenesis, and anti-oxidant effects, with potential therapeutic applications in various cancers and metabolic diseases.", "population_specificity": "Not specified (review of existing studies)", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:49:31.610555+00:00"}
{"study_id": 55844, "supplement_id": 1110, "safety_score": "Not Assessed", "efficacy_score": 75, "quality_score": 80, "study_goal": "The researchers aimed to explore the antioxidant and pro-oxidant roles of flavonoids, particularly Epigallocatechin Gallate (EGCG), in cancer prevention and treatment.", "results_summary": "The study found that EGCG and other flavonoids can inhibit carcinogenesis by suppressing ROS levels but may also induce oxidative stress to kill malignant cells. The review highlights the dual role of flavonoids in modulating ROS for anticancer effects.", "population_specificity": "Various cancers (not specified further)", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:49:32.413305+00:00"}
{"study_id": 55845, "supplement_id": 1110, "safety_score": "Not Assessed", "efficacy_score": null, "quality_score": null, "study_goal": "The researchers were exploring whether epigallocatechin gallate could be a potential candidate for treating kidney fibrosis, based on its use in idiopathic pulmonary fibrosis.", "results_summary": "The abstract mentions epigallocatechin gallate as a potential candidate for kidney fibrosis treatment but does not provide specific results regarding its effects.", "population_specificity": "Not specified (general discussion of kidney fibrosis in chronic kidney disease).", "effective_dosage": "Not provided", "study_duration": "Not provided", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:49:35.001098+00:00"}
{"study_id": 55846, "supplement_id": 1110, "safety_score": "Not Assessed", "efficacy_score": 75, "quality_score": 80, "study_goal": "The researchers aimed to review the structural activities, molecular mechanisms, and research progress of tea components, particularly epigallocatechin gallate, in anticancer effects.", "results_summary": "The study found that epigallocatechin gallate exhibits anticancer effects through mechanisms like inducing apoptosis, inhibiting cell proliferation, metastasis, and angiogenesis. Nano preparation technology was noted to improve its bioavailability and targeting.", "population_specificity": "Not specified (literature review of published studies and patents).", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:49:35.945964+00:00"}
{"study_id": 55847, "supplement_id": 1110, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 75, "study_goal": "The researchers aimed to review the effects of EGCG and its wound dressings on skin wound healing and scar prevention.", "results_summary": "The study found that EGCG and its wound dressings (hydrogels, nanoparticles, micro/nanofiber networks, microneedles) promote wound healing through antioxidant, anti-inflammatory, antimicrobial, angiogenesis, and antifibrotic properties across different stages of healing.", "population_specificity": "Not specified (review of existing literature).", "effective_dosage": "Not specified.", "study_duration": "Not specified.", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:49:37.242196+00:00"}
{"study_id": 55849, "supplement_id": 1110, "safety_score": "Not Assessed", "efficacy_score": 75, "quality_score": 65, "study_goal": "The researchers aimed to summarize the potential therapeutic effects of green tea and its major bioactive component, EGCG, on endometriosis by examining molecular and cellular mechanisms.", "results_summary": "The study suggests that EGCG may inhibit endometriosis growth through anti-angiogenic, anti-proliferative, anti-metastatic, and apoptosis-inducing properties, targeting inflammation, oxidative stress, invasion, adhesion, and angiogenesis. Preclinical studies support its potential therapeutic use, but clinical validation is needed.", "population_specificity": "Women with endometriosis (preclinical focus).", "effective_dosage": "Not specified.", "study_duration": "Not specified.", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:49:37.872559+00:00"}
{"study_id": 55848, "supplement_id": 1110, "safety_score": "Not Assessed", "efficacy_score": 75, "quality_score": 65, "study_goal": "The researchers aimed to determine if Epigallocatechin Gallate could modulate lncRNAs and their signaling pathways to manage lung cancer stem cells within the tumor microenvironment.", "results_summary": "The study found that Epigallocatechin Gallate, along with other natural phenolic compounds, effectively modulates lncRNAs and their upstream mediators, targeting signaling and epigenetic pathways to manage lung cancer stem cells. It was identified as a potential therapeutic agent for metastatic and drug-resistant lung cancers.", "population_specificity": "Lung cancer stem cells within the tumor microenvironment (in vitro or preclinical models, not specified).", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:49:38.175830+00:00"}
{"study_id": 55851, "supplement_id": 1110, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 75, "study_goal": "The researchers aimed to review the pharmacological actions, mechanisms, adverse effects, and clinical trial successes of catechin, including Epigallocatechin Gallate (EGCG).", "results_summary": "The study found that catechin and its isomers, including EGCG, exhibit anti-inflammatory, anti-diabetic, anti-cancer, neuroprotective, and other therapeutic effects by modulating pathways like NF-\u03baB, Nrf-2, TLR4/NF-\u03baB, COMT, and MAPKs. The mechanisms involve oxidative stress reduction and inflammation modulation.", "population_specificity": "Not specified (review article based on existing literature).", "effective_dosage": "Not specified.", "study_duration": "Not specified.", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:49:39.893203+00:00"}
{"study_id": 55852, "supplement_id": 1110, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 78, "study_goal": "The researchers aimed to summarize the anticancer mechanisms of Epigallocatechin Gallate (EGCG) and other bioactive compounds in the context of breast cancer.", "results_summary": "The study found that EGCG exhibits anticancer properties by modulating cell cycle arrest, apoptosis, inflammation, and angiogenesis, supported by in vitro and in vivo evidence. It highlights EGCG's potential as a future therapeutic candidate for breast cancer.", "population_specificity": "Not specified (review of in vitro and in vivo studies).", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:49:40.074360+00:00"}
{"study_id": 55853, "supplement_id": 1110, "safety_score": "Not Assessed", "efficacy_score": 75, "quality_score": 65, "study_goal": "The researchers aimed to summarize the potential of natural products, including Epigallocatechin Gallate, in treating or preventing IBD by targeting Th17/Treg cell imbalance.", "results_summary": "The abstract suggests that phytochemicals like Epigallocatechin Gallate may regulate Th17/Treg imbalance and offer protective benefits against colonic inflammation, supporting their potential as anti-colitis agents.", "population_specificity": "Not specified (general focus on IBD treatment).", "effective_dosage": "Not provided.", "study_duration": "Not specified.", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:49:41.762150+00:00"}
{"study_id": 55854, "supplement_id": 1110, "safety_score": "Not Assessed", "efficacy_score": 65, "quality_score": 85, "study_goal": "The researchers aimed to evaluate the potential of epigallocatechin gallate (EGCG) as part of combination therapies to revert signaling to a healthy-like state in multiple sclerosis (MS) patients.", "results_summary": "The study identified EGCG as an experimental therapy among other MS treatments and predicted its potential in combination therapies, particularly with TAK1 inhibitors, to restore healthy signaling. One predicted combination (fingolimod with a TAK1 inhibitor) was validated in an animal model.", "population_specificity": "129 MS patients (untreated or treated with various therapies, including EGCG) and 40 matched healthy controls.", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:49:44.155291+00:00"}
{"study_id": 55855, "supplement_id": 1110, "safety_score": "Not Assessed", "efficacy_score": 75, "quality_score": 65, "study_goal": "The researchers aimed to explore the role of Epigallocatechin Gallate (EGCG) in modulating the tumor microenvironment (TME) to inhibit cancer progression.", "results_summary": "EGCG was identified as a phytochemical with modulatory effects on TME, targeting molecular pathways in noncancer cells and inhibiting supportive effects for tumor development. However, more research is needed before clinical application.", "population_specificity": "Not specified (general focus on cancer progression mechanisms).", "effective_dosage": "Not provided", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:49:44.271939+00:00"}
{"study_id": 55856, "supplement_id": 1110, "safety_score": "Not Assessed", "efficacy_score": 70, "quality_score": 60, "study_goal": "The researchers aimed to evaluate whether Epigallocatechin Gallate (EGCG) could improve the effectiveness of gemcitabine chemotherapy for pancreatic ductal adenocarcinoma (PDAC) based on in vivo and/or in vitro studies.", "results_summary": "The abstract suggests promising data from preclinical studies for EGCG when combined with gemcitabine, but no clinical trials have been conducted yet to confirm these findings. EGCG is considered among dietary factors with potential to enhance gemcitabine therapy.", "population_specificity": "Preclinical studies (in vivo and/or in vitro), not yet tested in human clinical trials.", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:49:46.229878+00:00"}
{"study_id": 55857, "supplement_id": 1110, "safety_score": "Not Assessed", "efficacy_score": 85, "quality_score": 75, "study_goal": "The researchers aimed to evaluate the potential of Epigallocatechin Gallate (EGCG) as a treatment for endometriosis by targeting multiple molecular and signaling pathways involved in its pathophysiology.", "results_summary": "The study found that EGCG, as a natural product, has multiple targets and provides synergistic efficacy to address the complex pathophysiology of endometriosis, showing promising efficacy in treating the condition with minimal side effects.", "population_specificity": "Not specified (general endometriosis pathophysiology discussed).", "effective_dosage": "Not specified.", "study_duration": "Not specified.", "interactions": "None mentioned.", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:49:47.232131+00:00"}
{"study_id": 55858, "supplement_id": 1110, "safety_score": "70", "efficacy_score": 80, "quality_score": 75, "study_goal": "The researchers aimed to evaluate the effects of epigallocatechin gallate (EGCG) in mitigating heavy metal-induced toxicities across various cells and tissues.", "results_summary": "EGCG demonstrated protective effects against heavy metal toxicity in testis, liver, kidney, and neural cells through mechanisms like ROS scavenging, metal chelation, Nrf2 activation, anti-inflammatory effects, and mitochondrial protection. However, some in vitro studies reported EGCG could potentiate harmful heavy metal actions due to autooxidation and iron-related effects.", "population_specificity": "Cells and tissues (testis, liver, kidney, neural cells) exposed to heavy metals.", "effective_dosage": "Not specified", "study_duration": "Not specified", "interactions": "None mentioned", "analysis_prompt_version": "1.1", "last_analyzed_at": "2025-06-19T20:49:47.537229+00:00"}
